Misplaced Pages

Breast cancer awareness: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editContent deleted Content addedVisualWikitext
Revision as of 12:02, 30 November 2012 editWLU (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers, Rollbackers52,243 edits →The she-ro: wording← Previous edit Latest revision as of 23:16, 27 September 2024 edit undoWhatamIdoing (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers121,699 edits →Further reading: FormattingTag: 2017 wikitext editor 
(641 intermediate revisions by more than 100 users not shown)
Line 1: Line 1:
{{Short description|Effort to raise awareness and reduce the stigma of breast cancer}}
{{POV|date=November 2012}}
{{Distinguish|Breast awareness}}
'''Breast cancer awareness''' is an effort to ] and reduce the ] of ] through education on symptoms and treatment. Supporters hope that greater knowledge will lead to earlier detection of breast cancer, which is associated with higher long-term survival rates, and that money raised for breast cancer will produce a reliable, permanent cure.
{{Use dmy dates|date=July 2020}}
{{Use shortened footnotes|date=June 2022}}
] in ]]]

'''Breast cancer awareness''' is an effort to ] and reduce the ] of ] through education about ], ], and ]. Supporters hope that greater knowledge will lead to earlier detection of breast cancer, which is associated with higher ], and that money raised for breast cancer will produce a reliable, permanent ].


'''Breast cancer advocacy''' and awareness efforts are a type of ]. Breast cancer advocates ] and ] for better care, more knowledge, and more ]. They may conduct educational campaigns or provide free or low-cost services. '''Breast cancer culture''', sometimes called '''pink ribbon culture''', is the cultural outgrowth of breast cancer advocacy, the ] that supports it, and the larger ] movement. '''Breast cancer advocacy''' and awareness efforts are a type of ]. Breast cancer advocates ] and ] for better care, more knowledge, and more ]. They may conduct educational campaigns or provide free or low-cost services. '''Breast cancer culture''', sometimes called '''pink ribbon culture''', is the cultural outgrowth of breast cancer advocacy, the ] that supports it, and the larger ] movement.


The ] is the most prominent symbol of breast cancer awareness, and in most countries, the month of October is ]. National breast cancer organizations receive substantial financial support from ]s (King 2006, page 2). The ] is the most prominent symbol of breast cancer awareness, and in many countries, the month of October is ]. Some national breast ] receive substantial financial support from ]s.<ref>{{harvnb|King|2006|p=2}}</ref>

Breast cancer awareness campaigns have been criticized for ], ], and a ].


==Marketing approaches== ==Marketing approaches==
The goal of breast cancer awareness campaigns is to raise the public's "]" for breast cancer, its detection, its treatment, and the need for a reliable, permanent cure. Increased awareness has increased the number of women receiving mammograms, the number of breast cancers detected, and the number of women receiving biopsies (Sulik 2010, pages 157–210). Overall, as a result of awareness, breast cancers are being detected at an earlier, more treatable stage. Awareness efforts have successfully utilized marketing approaches to reduced the stigma associated with the disease. The goal of breast cancer ] is to raise the public's ] for breast cancer, its ], its ], and the need for a reliable, permanent cure. Increased awareness has increased the number of women receiving ], the number of breast cancers detected, and the number of women receiving ].<ref name=":0">{{harvnb|Sulik|2010|pp=157–210}}</ref> Overall, as a result of awareness, breast cancers are being detected at an earlier, more treatable stage. Awareness efforts have successfully utilized marketing approaches to reduce the stigma associated with the disease.<ref name=":0" />


Generally speaking, breast cancer awareness campaigns have been highly effective in getting attention for the disease. Breast cancer receives significantly more media coverage than other prevalent cancers, such as ] (Arnst 2007). Generally speaking, breast cancer awareness campaigns have been highly effective in getting ] for the disease. Breast cancer receives significantly more media coverage than other prevalent cancers, such as ].<ref>{{harvnb|Arnst|2007}}</ref>


===Breast cancer as a brand===
===Events===
], promote breast cancer awareness.]] ], an international symbol of breast cancer awareness.]]
Breast cancer advocacy uses the ] and the color ] as a ] to raise money and increase screening. The breast cancer brand is strong: people who support the "pink brand" are members of the ] ], who are in favor of improved lives for women, believe in ], trust ] to be able to solve any problem if given enough money, and prefer curative treatments to prevention.<ref>{{harvnb|Sulik|2010|p=22}}; {{harvnb|King|2006|p=38}}</ref>
{{Main|National Breast Cancer Awareness Month}}


The brand ties together fear of cancer, hope for early identification and successful treatment, and the ] of women with breast cancer and anyone who visibly identifies themselves with breast cancer patients. This brand permits and even encourages people to substitute ] and individual ]s, like buying or wearing a pink ribbon, for concrete, practical results, such as ] aimed at discovering non-genetic causes of breast cancer.<ref>{{harvnb|Sulik|2010|pp=133–146}}</ref>
Each year, the month of October is recognized as ] by most governments, the media, and ]. The month-long campaign has been called ''Pinktober'' because of the proliferation of pink goods for sale, and ''National Breast Cancer Industry Month'' by critics like ] (Sulik 2010, pages 48, 370). NBCAM was begun in 1985 by the ] (ACS) and pharmaceutical company ]. The organization that runs the official NBCAM aims to promote ] and other forms of early detection as the most effective means of saving lives (King 2006, page xxi).


The establishment of the brand and the entrenchment of the breast cancer movement has been uniquely successful because no ] opposes the breast cancer movement or believes that breast cancer is desirable.<ref>{{harvnb|King|2006|p=111}}</ref>
Typical NCBAM events include fundraising-based ]s, ], and ] (Ehrenreich 2001). Participants solicit donations to a breast cancer-related charity, in return for their promise to run, walk, or ride in the event. Through mass-participation events, breast cancer survivors form a single, united group that speaks and acts consistently and shares a coherent set of beliefs. There are little significant discrepancies among individuals (Sulik 2010, page 56). They also reinforce the cultural connection between each individual's ] and ] (King 2006, pages 46–49). Typically, one-quarter to one-third of the money donated is spent on advertising and organizing the event itself (Ehrenreich 2001).


===Pink ribbon===
Various ]s are illuminated in pink lights as a visible reminder of breast cancer, and public events, such as American football games, may use pink equipment or supplies. In 2010, all ] comic strips on one Sunday were printed in shades of red and pink, with a pink ribbon logo appearing prominently in one panel.
{{Main|Pink ribbon}}


A pink ribbon is a ] of breast cancer awareness. It may be worn to honor those who have been diagnosed with breast cancer, or to identify products that a manufacturer would like to sell to consumers that are interested in breast cancer. Pink ribbons are sometimes sold as ], much like ].<ref>{{Harvnb|Moore|2008|p=43, 65}}</ref>
Private companies may arrange a "pink day", in which employees wear pink clothes in support of breast cancer patients, or pay for the privilege of a relaxed ], such as ] (Ehrenreich 2001).


The pink ribbon is associated with individual ], ] in scientific progress, and an optimistic "can-do" attitude. It encourages individuals to focus on the emotionally appealing ultimate ] of a cure for breast cancer, rather than the reality that there is neither any certain cure for breast cancer nor any guarantee there will ever be such a cure.<ref>{{harvnb|Sulik|2010|pp=359–361}}</ref> The practice of blindly wearing or displaying a pink ribbon without making other, more concrete efforts to prevent or cure breast cancer has been described as a kind of ] due to its lack of real effects,<ref>{{harvnb|Landman|2008}}</ref> and has been compared to equally simple yet ineffective "awareness" practices like the drive for women to post the colors of their bras on ].<ref>{{harvnb|Borrelli|2010}}</ref> Critics say that the feel-good nature of pink ribbons and "pink consumption" distracts society from the lack of progress in curing breast cancer.<ref>{{harvnb|Sulik|2010|pp=365–366}}</ref> It is also criticized for reinforcing ] and ] women and their breasts.<ref>{{harvnb|Sulik|2010|pp=372–374}}</ref>
Some events are directed at people in specific communities, such as the ], which was started in America to encourage appropriate medical care and reduce the stigma of breast cancer among Muslim women, and ''Male Breast Cancer Awareness Week'', which some organizations highlight during the third week of October.


===Events===
Most events are well-received, but some, like the unauthorized painting of the ] in ], are controversial.
], promote breast cancer awareness.]]
{{Main|Breast Cancer Awareness Month}}


Each year, the month of October is recognized as ] by many governments, the media, and ]. The month-long campaign has been called ''Pinktober'' because of the increased production of pink goods for sale, and ''National Breast Cancer Industry Month'' by critics like ].<ref>{{harvnb|Sulik|2010|pp=48, 370}}</ref> BCAM was begun in 1985 by the ] and pharmaceutical company ]. The organization that runs the official BCAM aims to promote ] and other forms of early detection as the most effective means of fighting breast cancer.<ref>{{harvnb|King|2006|p=xxi}}</ref>
] campaigns have encouraged users to use ] and ] in their status updates to remind readers about breast cancer. In 2009, a campaign asked women to post the color of their ], and in 2010, a campaign asked women to post where they keep their purses, resulting in status messages such as "I like it on the floor" (Kingston 2010). These campaigns have been criticized as ] the disease (Kingston 2010).


Typical BCAM events include fundraising-based ]s, ], and ].<ref>{{harvnb|Ehrenreich|2001}}</ref> Participants solicit donations to a breast cancer-related charity in return for running, walking, or riding in the event. Through mass-participation events, breast cancer survivors form a single, united group that speaks and acts consistently and shares a coherent set of beliefs.<ref>{{harvnb|Sulik|2010|p=56}}</ref> They also reinforce the cultural connection between each individual's ] and ].<ref>{{harvnb|King|2006|pp=46–49}}</ref> Events organized by Avon or Komen are known to allocate around 25%-33% of donations to the funds needed to organize the event and advertise it.<ref>{{harvnb|Ehrenreich|2001}}</ref>
Mere symbolism itself does not prevent cancer, improve treatments, or save lives. However, it is an effective form of promoting the pink ribbon culture: fear of breast cancer, the hope for a scientific breakthrough, and the goodness of the people who support the cause. These supporters may feel socially compelled to participate, in a type of "obligatory voluntarism" that critics say is "exploitative" (Sulik 2010, page 250, 308).


]
===Pink ribbon===
], a universal symbol of breast cancer awareness.]]
{{Main| Pink ribbon}}


Various ]s are illuminated in pink lights as a visible reminder of breast cancer, and public events, such as American football games, may use pink equipment or supplies.<ref>{{Harvnb|Elliott|2009}}</ref><ref>{{Harvnb|King|2006|p=xx}}</ref><ref>{{Harvnb|King|2006|p=15–18}}</ref> In 2010, all ] comic strips on one Sunday were printed in shades of red and pink, with a pink ribbon logo appearing prominently in one panel.<ref>{{Harvnb|Gustines|2010}}</ref>
A ] is a symbol of breast cancer awareness. It may be worn to honor those who have been diagnosed with breast cancer, or to identify products that a manufacturer would like to sell to consumers that are interested in breast cancer. Pink ribbons are sometimes sold as fundraisers, much like ].


Private companies may arrange a "pink day", in which employees wear pink clothes in support of breast cancer patients, or pay for the privilege of a relaxed ], such as ].<ref>{{harvnb|Ehrenreich|2001}}</ref> Some events are directed at people in specific communities, such as the ], which was started in America to encourage appropriate medical care and reduce the stigma of breast cancer among Muslim women, and Male Breast Cancer Awareness Week, which some organizations highlight during the third week of October. Most events are well-received, but some, like the unauthorized painting of the ] in ], are controversial.
The pink ribbon is associated with individual generosity, faith in scientific progress, and an optimistic "can-do" attitude. It encourages individuals to focus on the emotionally appealing ultimate vision of a cure for breast cancer, rather than the true possibility of a timely future cure considering current progress (Sulik 2010, pages 359–361). Despite these positive associations, the simple act of wearing a pink ribbon alone and promoting it as a symbol for breast cancer has not been credited with saving any lives. The practice of blindly wearing or displaying a pink ribbon without making other, more concrete efforts to cure breast cancer has been described as a kind of ] due to its lack of real effects (Landman 2008), and compared to equally simple yet ineffective "awareness" practices like the drive for women to post the colors of their bras on ] (Borrelli, 2010). Critics say that the feel-good nature of pink ribbons and "pink consumption" distracts society from the lack of progress in curing breast cancer (Sulik 2010, pages 365–366). It is also criticized for reinforcing gender stereotypes and ] women and their breasts (Sulik 2010, pages 372–374).


Many ]s find that BCAM is an emotionally difficult time, as it reminds them of a ] time and because the cheerful marketing images do not match their experiences.<ref>{{Harvnb|Burns|2021}}</ref>
===Shopping for the cure===
Thousands of breast cancer-themed products are developed and sold each year (Ave 2006). Some of these, like ] and ]s, have no purpose other than as a type of ] that displays the wearer's interest in breast cancer. Others are everyday products that have been repackaged or repositioned to take advantage of ], such as teddy bears, clothing, jewelry, candles, and coffee mugs (Ehrenreich 2001). These ] objects offer consumers an opportunity to simultaneously buy an object and make a donation to a breast cancer organization (Ehrenreich 2001). Some of these products are produced and/or sold by breast cancer survivors or charities for fundraising purposes, while others are for profits in addition to fundraising. Manufacturers also produce products with pink labels or pink ribbon logos to donate a sum of money to support the cause (Levine 2005). The donation is typically capped so that it is reached after a fixed level of sales, although in some cases the company is providing only free advertising for a selected charity. Although advertising costs are rarely disclosed, some companies have been found to spend far more money advertising "pink products" and tie-ins than they donate to charitable organizations supporting research or patients. For example, in 2005, ] spent US $500,000 advertising ] notes printed with a pink ribbon logo. Sales were nearly double what the company expected, but the campaign resulted in a $300,000 donation (Levine 2005).


===Companies and consumers===
Pink products have also been condemned as promoting ], ], and environmental degradation. Critics are also concerned that the ubiquity of pink products may mislead people into thinking that significant progress has been made, and that small, individual actions, like buying a breast cancer-themed product, are sufficient (Stukin 2006).
], including ], ink pens, candy, and ]s.]]
Thousands of breast cancer-themed products are developed and sold each year.<ref>{{harvnb|Ave|2006}}</ref> Some of these items are everyday products that have been repackaged or repositioned to take advantage of ], such as teddy bears, clothing, jewelry, candles, and coffee mugs.<ref>{{harvnb|Ehrenreich|2001}}</ref> These ] objects offer consumers an opportunity to simultaneously buy an object and make a donation to a breast cancer organization.<ref>{{harvnb|Ehrenreich|2001}}</ref> Some of these products are produced and/or sold by breast cancer survivors or charities for fundraising purposes, while others are for profits in addition to fundraising. Manufacturers also produce products with pink labels or pink ribbon logos to donate a sum of money to support the cause.<ref>{{harvnb|Levine|2005}}</ref> The donation is typically capped so that it is reached after a fixed level of sales, although in some cases the company is providing only free advertising for a selected charity. Although advertising costs are rarely disclosed, some companies have been found to spend far more money advertising "pink products" and tie-ins than they donate to charitable organizations supporting research or patients. For example, in 2005, ] spent US$500,000 advertising ] notes printed with a pink ribbon logo. Sales were nearly double what the company expected, but the campaign resulted in a $300,000 donation.<ref>{{harvnb|Levine|2005}}</ref>


Advertisers and retail consultants have said that because of consumer cynicism, a company can benefit from marketing its support for a cause such as breast cancer awareness only when the company treats that support as "a commitment and not a marketing opportunity". Andrew Benett, an executive at ] said that because consumers "have become more mindful, more thoughtful, about how they consume, where they consume, why they consume", companies cannot succeed by "just slapping a pink ribbon on a product and people will buy more".<ref>{{harvnb|Elliott|2009}}</ref> Pink products have also been condemned as promoting ], ], and ]. Critics are also concerned that the ubiquity of pink products may mislead people into thinking that significant progress has been made, and that small, individual actions, like buying a breast cancer-themed product, are sufficient.<ref>{{harvnb|Stukin|2006}}</ref> Responding to criticism, Komen CEO ] said that corporate promotions enabled the organization to reach new audiences and that "America is built on consumerism. To say we shouldn't use it to solve the social ills that confront us doesn't make sense to me".<ref>{{harvnb|Singer|2011}}</ref>
The first breast cancer awareness stamp in the U.S., featuring a pink ribbon, was issued in 1996. As it did not sell well, a ] stamp without a pink ribbon, the ], was designed in 1998. Products like these emphasize the relationship between being a consumer and supporting women with breast cancer (King 2006, pages 61–79).


In Canada, the Royal Canadian Mint produced 30 million 25-cent coins with pink ribbons during 2006 for normal circulation (Royal Canadian Mint 2006). Designed by the mint's director of engraving, Cosme Saffioti (reverse), and Susanna Blunt (obverse), this colored coin is the second in history to be put into regular circulation (Royal Canadian Mint 2006). The first breast cancer awareness stamp in the U.S., featuring a pink ribbon, was issued in 1996. As it did not sell well, a ] stamp without a pink ribbon, the ], was designed in 1998. Products like these emphasize the relationship between being a consumer and supporting women with breast cancer.<ref>{{harvnb|King|2006|pp=61–79}}</ref> In Canada, the Royal Canadian Mint produced 30 million 25-cent coins with pink ribbons during 2006 for normal circulation.<ref>{{harvnb|Royal Canadian Mint|2006}}</ref> Designed by the mint's director of engraving, Cosme Saffioti (reverse), and Susanna Blunt (obverse), this colored coin is the second in history to be put into regular circulation.<ref>{{harvnb|Royal Canadian Mint|2006}}</ref>
]


Business marketing campaigns, particularly sales promotions for products that increase pollution or contribute to breast cancer, such as alcohol, high-fat foods, some pesticides, or the ] and ] used by most cosmetic companies, have been condemned as ] (a ] of ''pink ribbon'' and ]) (Mulholland 2010). Such promotions generally result in a token donation to a breast cancer-related charity by taking advantage of the consumers' fear of cancer and grief for people who have died to drive sales (Landman 2008). Critics say that these promotions, which net more than US $30 million each year just for fundraising powerhouse ], do little more than support the marketing machines that produce them (Stukin 2006). Business marketing campaigns, particularly sales promotions for products that increase pollution or have been linked to the development of breast cancer, such as alcohol, high-fat foods, some pesticides, or the ] and ] used by most cosmetic companies, have been condemned as ] (a ] of ''pink ribbon'' and ]).<ref>{{harvnb|Mulholland|2010}}</ref> Such promotions generally result in a token donation to a breast cancer-related charity by taking advantage of the consumers' fear of cancer and grief for people who have died to drive sales.<ref>{{harvnb|Landman|2008}}</ref> Critics say that these promotions, which net more than US$30 million each year just for fundraising powerhouse ], do little more than support the marketing machines that produce them.<ref>{{harvnb|Stukin|2006}}</ref> Komen says that corporate sponsorships are necessary to pay for the organization's efforts: in the 2010 ] it spent $175 million on public health education and awareness campaigns, $75 million on medical research and about $67 million on treatment and screenings for patients.<ref>{{harvnb|Singer|2011}}</ref>


Two significant campaigns against pink consumption are the ]'s "Not Just Ribbons" campaign, and ]'s "Think Before You Pink" campaign. NBCC's "Not Just Ribbons" which opposed the hypocrisy of people and businesses who use pink ribbons to promote their products or themselves, but ignore or oppose substantive issues, such as ], access to medical care, ], and anti-pollution legislation (Sulik 2010, pages 366–368). "Think Before You Pink" encouraged consumers to ask questions about pink products (e.g., to find out how much of a donation was being made) (Sulik 2010, pages 369–372). Two significant campaigns against pink consumption are the ]'s "Not Just Ribbons" campaign, and Breast Cancer Action's "Think Before You Pink" campaign. NBCC's "Not Just Ribbons" campaign sought to focus awareness efforts onto substantive issues such as ], access to cancer treatment, ], and environmental breast cancer research.<ref>{{harvnb|Sulik|2010|pp=366–368}}</ref> "Think Before You Pink" encouraged consumers to ask questions about pink products (e.g., to find out how much of a donation was being made).<ref>{{harvnb|Sulik|2010|pp=369–372}}</ref>


===Advertisements=== ===Advertisements===
] advertisement promotes ] company ] and breast cancer awareness. Because of the pink ribbon brand's strength, the advertisement is easily recognized as a promotion for breast cancer awareness, even among people who cannot read the Japanese text.]] ] advertisement promotes ] company ] and breast cancer awareness. Because of the pink ribbon brand's strength, the advertisement is easily recognized as a promotion for breast cancer awareness, even among people who cannot read the Japanese text.]]
Many corporate and charitable organizations run advertisements related to breast cancer, especially during National Breast Cancer Awareness Month, in the hope of increasing sales by aligning themselves with a positive, helpful message (King 2006). In addition to selling pink products, corporate advertisements may promote the company's progressive policies, or may provide ] for a chosen charity. Medical institutions may run advertisements for ] or other breast-related services. Non-profit organizations often benefit from ]s, which are free advertisements provided by newspapers, radio and television stations, and other media. Many corporate and charitable organizations run advertisements related to breast cancer, especially during National Breast Cancer Awareness Month, in the hope of increasing sales by aligning themselves with a positive, helpful message.<ref>{{harvnb|King|2006}}</ref> In addition to selling pink products, corporate advertisements may promote the company's progressive policies, or may provide ] for a chosen charity. Medical institutions may run advertisements for ] or other breast-related services. Non-profit organizations often benefit from ]s, which are free advertisements provided by newspapers, radio and television stations, and other media. Some marketing blurs the line between advertisements and events, such as ]s as a form of ]. The typical participant in the breast cancer movement, and therefore the advertisers' ], is a white, middle-aged, middle-class, well-educated woman.<ref>{{harvnb|King|2006|pp=110–111}}</ref>


Some corporate sponsors are criticized for having a ]. For example, some of the prominent sponsors of these advertisements include businesses that sell the expensive equipment needed to perform screening mammography; an increase in the number of women seeking mammograms means an increase in their sales, which has led critics to say that their sponsorship is not a voluntary act of charity, but an effort to increase sales.<ref>{{harvnb|King|2006|p=37}}</ref> The regulated drug and medical device industry uses the color pink, positive images, and other themes of the pink ribbon culture in ] to associate their breast cancer products with the fear, hope, and wholesome goodness of the breast cancer movement. This is particularly evident in advertisements designed to sell screening mammograms.<ref>{{harvnb|Sulik|2010|pp=205–208}}</ref>
Some marketing blurs the line between advertisements and events, such as ]s as a form of ].

The typical participant in the breast cancer movement, and therefore the advertisers' ], is a white, middle-aged, middle-class, well-educated woman (King 2006, pages 110–111).

Some corporate sponsors are criticized for having a ]. For example, some of the prominent sponsors of these advertisements include businesses that sell the expensive equipment needed to perform screening mammography; an increase in the number of women seeking mammograms means an increase in their sales. Their sponsorship is thus not a voluntary act of charity, but an effort to increase their sales (King 2006, page 37). The regulated drug and medical device industry uses the color pink, positive images, and other themes of the pink ribbon culture in ] to associate their breast cancer products with the fear, hope, and wholesome goodness of the breast cancer movement (Sulik 2010, page 206–208). This is particularly evident in advertisements designed to sell screening mammograms.

Despite having been determined to be ineffective in low-risk and average-risk women, many charities still advertise ]s as a means of simultaneously raising awareness, encouraging early detection, and increasing the visibility of their organizations. Other organizations' advertisements now advocate ], which is paying attention to any ] that may require medical attention.

===Media===
Although more women die from ], breast cancer receives far more attention in ]s than any other cancer. Until the mid-1990s, nearly all of these stories were written from the perspective of the expert, who gave advice. Since then, the ], describing the personal experiences of individual patients, has become more prominent. (Sulik 2010, page 133).

], ] and frequent feature stories amount to free advertising for the brand and for the organizations that support it.

==Breast cancer as a brand==
], including ], ink pens, candy, and ]s.]]

Breast cancer advocacy uses a the ] and the color ] as a ] to raise money and increase screening. The breast cancer brand is strong: people who support the "pink brand" are members of the ] ], who are in favor of improved lives for women, trust biomedical science and believe in a future without breast cancer (Sulik 2010, page 22).

The brand ties together fear of cancer, hope for early identification and successful treatment, and the ] of women with breast cancer and anyone who visibly identifies themselves with breast cancer patients. This brand permits and even encourages people to substitute ] and individual ]s, like buying or wearing a pink ribbon, for concrete, practical results, such as ] aimed at discovering non-genetic causes of breast cancer (Sulik 2010, pages 133–146).

The establishment of the brand and the entrenchment of the breast cancer movement has been uniquely successful, because no ] opposes the breast cancer movement or believes breast cancer to be desirable (King 2006, page 111).


==Social role of the woman with breast cancer== ==Social role of the woman with breast cancer==
] chemotherapy for ]. She keeps ice packs on her hands and feet to reduce temporary damage to her fingernails and toenails.]]

The marketing of breast cancer awareness allows people to choose support for awareness as a ] or ]. Socially aware, pro-woman individuals, businesses, politicians, and organizations use pink ribbons and other trappings of breast cancer awareness to signal their support for women, health, and mainstream medicine. The marketing of breast cancer awareness allows people to incorporate support for awareness into their ] or ]. Socially aware, pro-woman individuals, businesses, politicians, and organizations use pink ribbons and other trappings of breast cancer awareness to signal their support for women, health, and mainstream medicine.<ref>{{Harvnb|Sulik|2010|p=125–145 <!--This paragraph summarizes most of section four in this book, "Consuming Pink: Mass Media and the Conscientious Consumer". This 21-page spread is only the most relevant fraction of that section. -->}}</ref>


===The she-ro=== ===The she-ro===
The term ''she-ro'', derived from ], is used in discussions of breast cancer to refer to women who have been diagnosed with breast cancer, and sometimes to those who have survived breast cancer. The term describes an "idealized" patient who combines assertiveness, optimism, femininity and sexuality, despite the effects of treatment, and as a "paragon uses a diagnosis of breast cancer as a catalyst for a personal transformation".<ref>{{harvnb|Zuger|2010}}</ref>


The term "she-ro", derived from ], used in discussions of breast cancer to refer to women who have been diagnosed with, and sometimes having survived breast cancer. The term describes an "idealized" patient who combines assertiveness, optimism, femininity and sexuality, despite the effects of treatment, and as a "paragon uses a diagnosis of breast cancer as a catalyst for a personal transformation" (Zuger, 2010). ] Gayle Sulik analysis of the she-ro's social ] ascribed it qualities that include being an educated medical consumer with a brave, pleasant and ] public appearance and demeanor who aggressively fights breast cancer through compliance with mainstream medical advice. In ] the she-ro is diagnosed early due to rigid adherence to early ] recommendations, and survives her diagnosis (Sulik 2010, page 158, 243). The role emphasizes the ] and female ] of the she-ro, offsetting the ] characteristics of assertiveness, selfishness and "fighting" cancer by cultivating a feminine appearance and concern for others (Sulik 2010, pages 78–89). After treatment, the she-ro regains her femininity by using ], prosthetic devices, wigs, cosmetics, and clothing to present an aesthetically appealing, upper-class, heterosexual feminine appearance and by maintaining relationships in which she can nurture other people (Sulik 2010, page 42, 374). Programs such as Reach to Recovery and Look Good, Feel Better educate breast cancer patients of this cultural standard and help them conform to it (Olson 2002, page 120; Sulik 2010, pages 37–38). Ensuring of the proper ] of the breast cancer culture is encouraged, including remaining optimistic of a full cure, rationalizing the selfishness of treatment as a temporary measure and feeling guilty that it forces her to put her needs momentarily above the needs of others or due to her perceived inadequacy in caring her family or other women with cancer (Sulik 2010, pages 225–272, 277). Also included in the role is a form of have-it-all ], cultivating a normal appearance and activity level and minimizing the disruption that breast cancer causes to people around her (Sulik 2010, pages 279–301). ] Gayle Sulik analyzed the she-ro's ] and ascribes it qualities that include being an educated medical ] with a brave, pleasant and ] public appearance and demeanor, who aggressively fights breast cancer through compliance with screening guidelines and "disciplined practice of 'breast health{{'"}}. In ] the she-ro is diagnosed early due to adherence to early ] recommendations, and, by definition, she survives her diagnosis and treatment.<ref>{{harvnb|Sulik|2010|pp=158, 243}}</ref> The role emphasizes the ] and female ] of the she-ro, offsetting the ] characteristics of assertiveness, selfishness and "fighting" cancer by cultivating a feminine appearance and concern for others.<ref>{{harvnb|Sulik|2010|pp=78–89}}</ref> During and after treatment, the she-ro regains her femininity by using breast reconstruction, prosthetic devices, wigs, cosmetics, and clothing to present an aesthetically appealing, upper-class, heterosexual feminine appearance and by maintaining relationships in which she can nurture other people.<ref>{{harvnb|Sulik|2010|pp=42, 101–105, 374}}</ref> Following the proper ] of the breast cancer culture is encouraged, including remaining optimistic of a full cure, rationalizing the selfishness of treatment as a temporary measure, and ] that it forces her to put her needs momentarily above the needs of others or due to her perceived inadequacy in caring for her family or other women with cancer.<ref>{{harvnb|Sulik|2010|pp=225–272, 277}}</ref> Also included in the role is a form of the have-it-all ], cultivating a normal appearance and activity level and minimizing the disruption that breast cancer causes to people around her.<ref>{{harvnb|Sulik|2010|pp=279–301}}</ref>


====Consequences==== ====Consequences====
The effort of maintaining the role of a she-ro can be stressful. The role encourages women to care for others rather than themselves, which the patient may find comforting, but this may lead to the reluctance or inability to ask for help they need or want which can lead to bitterness that their friends and family did not offer these services unbidden (Sulik 2010, pages 279–301). The success of their normalization efforts may paradoxically increase their dissatisfaction, as their apparent ability to handle it all discourages people from offering help (Sulik 2010, page 283, 286). While the she-ro model may reduce the ] of breast cancer overall, it also increases the stigma of being overwhelmed, depressed, anxious, abrasive, or unattractive while undergoing treatment (Sulik 2010, page 45). The culture celebrates women who display the attitude deemed correct, and declares that their continued survival is due to this positive attitude and fighting spirit, even though cheerfulness, hope, and displaying a cosmetically enhanced appearance do not kill cancer cells (Sulik 2010, page 243–244). Women who reject the she-ro model may find themselves socially isolated by the breast cancer ]s that are nominally supposed to help them. Support from "the sisterhood" is reserved for the "passionately pink", rather than those whose response is deemed inappropriate because it is angry, unhappy, or afraid (Sulik 2010, page 274–277). The breast cancer culture is also ill-equipped to deal with women who are dying or who have died (Sulik 2010, page 4). Despite occasional efforts at memorials, such as displaying the names of women who have died, these women's experiences are not validated and represented. They are, instead, ignored and shunned as failures and as hope-destroying examples of reality. Similarly, the culture is ill-equipped to deal with the news that a previously hyped treatment or screening procedure has been determined to be ineffective, with women demanding acceptance and promotion of useless activities and harmful drugs (Ehrenreich 2001; Olson 2002, pages 204–205; Sulik 2010, pages 200–203). The effort of maintaining the role of a she-ro can be stressful. The role encourages women with breast cancer to care for others rather than themselves. Some of them find this comforting, but it may lead to them feeling reluctant or unable to ask for the help they need or want, and this can lead to bitterness that their friends and family did not offer these services unbidden.<ref>{{harvnb|Sulik|2010|pp=279–301}}</ref> The success of their efforts to look and act normally may paradoxically increase their dissatisfaction, as their apparent ability to handle it all discourages people from offering help.<ref>{{harvnb|Sulik|2010|pp=283, 286}}</ref>


The breast cancer culture celebrates women who display the attitude deemed correct, which implies that their continued survival is due to this ] and fighting spirit. While cheerfulness, hope, and good social support can be advantageous to health outcomes, it cannot determine survival rates.<ref>{{harvnb|Sulik|2010|pp=243–244}}</ref> Women who reject the she-ro model may find themselves socially isolated by the breast cancer ]s that are nominally supposed to help them. Support from "the sisterhood" favors the "passionately pink", and tends to overlook women whose response to being diagnosed with breast cancer is incompatible with the pink ribbon culture, because they feel angry, unhappy, or afraid.<ref>{{harvnb|Sulik|2010|pp=274–277}}</ref>
===Breast cancer culture===


The breast cancer culture is ill-equipped to deal with women who are dying or who have died,<ref>{{harvnb|Sulik|2010|p=4}}</ref> and their experiences may not be memorialized, validated or represented as part of the movement, instead being ignored or shunned as failures and as hope-destroying examples of reality. They may feel like treatment failure is a "dirty little secret" that others want to make invisible.<ref>{{Harvnb|Burns|2021}}</ref> Similarly, the culture is also ill-equipped to deal with the news that a previously hyped treatment or screening procedure has been determined to be ineffective, with women advocating for the acceptance and promotion of inexpedient activities and inefficient or even sometimes harmful drugs.<ref>{{harvnb|Ehrenreich|2001}}; {{harvnb|Olson|2002|pp=204–205}}; {{harvnb|Sulik|2010|pp=200–203}}</ref>
{{Undue-section|date=November 2012}}


===Breast cancer culture===
Breast cancer culture, or pink ribbon culture, is the set of activities, attitudes, and values that surround and shape breast cancer in public. The dominant values are selflessness, cheerfulness, unity, and optimism. The she-ro uses the emotional trauma of being diagnosed with breast cancer and the suffering of extended treatment to transform herself into a stronger, happier and more sensitive person who is grateful for the opportunity to become a better person. In particular, she sees breast cancer as an opportunity to give herself permission for necessary personal growth—permission that she felt unable to give herself before, because of the restraints of her ] (Sulik 2010, page 236). Breast cancer thereby becomes a ] rather than a disease (Ehrenreich 2001; Sulik 2010, page 3).


Breast cancer culture, or pink ribbon culture, is the set of activities, attitudes, and values that surround and shape breast cancer in public. The dominant values are selflessness, cheerfulness, unity, and optimism. It is pro-doctor, pro-medicine, and pro-mammogram. Health care professionals are sources of information, but the rightness of their advice is not to be seriously questioned by women with breast cancer. Patients are not encouraged to ask where research money is going or if the research industry is making progress in finding the "cure".<ref>{{harvnb|Sulik|2010|pp=365–366}}</ref> The emphasis on cheerfulness allows society to blame women for developing breast cancer and limits their responses to certain ]. The requirement of cheerful optimism arose from the then-popular theory that cancer had a ] origin and that people who were diagnosed with cancer had a "cancer personality" that was depressed, repressed, and self-loathing. ] was therefore considered an adjunct treatment used to produce a cheerful, self-affirming identity. This theory was predominant among psychiatrists through the 1970s, but has since been discredited.<ref>{{harvnb|Olson|2002|pp=460–469}}; {{harvnb|Sulik|2010|p=342}}</ref> In a process called ], the she-ro uses the emotional trauma of being diagnosed with breast cancer and the suffering of extended treatment to transform herself into a stronger, happier and more sensitive person who is grateful for the opportunity to become a better person. In particular, she sees breast cancer as an opportunity to give herself permission for necessary personal growth that she felt she was prohibited from or unable to make before.<ref>{{harvnb|Sulik|2010|p=236}}</ref> Breast cancer thereby becomes a ] rather than a disease,<ref>{{harvnb|Ehrenreich|2001}}; {{harvnb|Sulik|2010|p=3}}</ref> with pink ribbon culture honoring the suffering of its she-roes by selecting them based on the amount of misery they have experienced,<ref>{{harvnb|Sulik|2010|p=319}}</ref> and leading women whose treatment is less painful or debilitating to feel excluded and devalued. The suffering, particularly the extended suffering of months of chemotherapy and radiation treatment, forms a ]ical type of ] or rite of passage that initiates women into the inner circle of breast cancer culture. ] describes it this way:
The emphasis on cheerfulness allows society to blame women for developing breast cancer and to the limit their responses to culturally approved scripts. The requirement of cheerful optimism arises from a now-discredited idea that people who were diagnosed with cancer had a "cancer personality" that was depressed, repressed, and self-loathing. The cure for cancer was therefore ] to produce a cheerful, self-affirming identity (Olson 2002, pages 460–469; Sulik 2010, page 342).
<blockquote>Understood as a rite of passage, breast cancer resembles the initiation rites so exhaustively studied by Mircea Eliade: First there is the selection of the initiates—by age in the tribal situation, by mammogram or palpation here. Then come the requisite ordeals—scarification or circumcision within traditional cultures, surgery and chemotherapy for the cancer patient. Finally, the initiate emerges into a new and higher status—an adult and a warrior—or in the case of breast cancer, a "survivor".<ref>{{harvnb|Ehrenreich|2001}}</ref></blockquote>


Mainstream pink ribbon culture has aspects that are trivializing, silencing, and ].<ref>{{harvnb|Sulik|2010|p=98}}</ref> Women with breast cancer are surrounded by childish kitsch such as pink teddy bears and crayons, but there is no equivalent gift of toy cars for men diagnosed with ].<ref>{{harvnb|Ehrenreich|2001}}; {{harvnb|Sulik|2010|p=373}}</ref> Women who choose not to conform to the culture may feel excluded and isolated; those who cannot conform to the prescribed triumphant script report feeling unable to share their stories honestly. Anger, negativity and fatalism transgress the feeling rules, and women with breast cancer who express anger or negativity are corrected by other women with breast cancer and members of the breast cancer support organizations.<ref>{{harvnb|Ehrenreich|2001}}; {{harvnb|Sulik|2010|pp=240–242}}</ref> Appearing unattractive—such as going out in public with a bare, bald head if treatment causes temporary hair loss—transgresses the approved, upper-class style of pink femininity and provokes shaming comments from strangers.<ref>{{harvnb|Sulik|2010|pp=35–45, 262}}</ref> Programs such as Reach to Recovery and Look Good, Feel Better inform breast cancer patients of this cultural standard and help them conform to it.<ref>{{harvnb|Olson|2002|p=120}}; {{harvnb|Sulik|2010|pp=37–38, 42, 101–105, 374}}</ref> This standard is not universally adhered to in every detail. Ehrenreich says that "he question of wigs versus baldness&nbsp;... defines one of the few real disagreements in breast-cancer culture." Some women have '']'' aesthetic tastes: "One decorates her scalp with ]s of peace signs, panthers, and frogs; another expresses herself with a shocking purple wig; a third reports that unadorned baldness makes her feel 'sensual, powerful, able to recreate myself with every new day{{'"}}.<ref>{{harvnb|Ehrenreich|2001}}</ref> Regardless of whether the transformation is towards a radical, natural or cosmetically enhanced appearance, treatment is always "a ] opportunity".<ref>{{harvnb|Ehrenreich|2001}}</ref>
Pink ribbon culture is pro-doctor, pro-medicine, and pro-mammogram. Health care professionals are sources of information, but the rightness of their advice is not to be seriously questioned. Patients are not encouraged to notice the absence of any meaningful method of prevention or treatments that are non-mutilating, non-debilitating, or noticeably more successful than what existed in the 1930s (Sulik 2010, pages 365–366).


Since the beginning of the 21st century, breast cancer culture has become more sexualized, and many awareness campaigns now reflect the old advertising truism that ]. The "booby campaigns", such as "Save the Tatas" and the "I ♥ Boobies" gel bracelets, rely on a cultural obsession with breasts and a market that is already highly aware of breast cancer.<ref>{{harvnb|Kingston|2010}}</ref> This message trivializes women and reflects a belief that breast cancer is important because cancer and its treatment makes women feel less sexually desirable and interferes with men's sexual access to women's breasts, instead of because cancer and its treatment kill and disable women.<ref>{{harvnb|Sulik|2010|pp=372–374}}</ref> These sexualized campaigns tend to attract a younger audience than traditional campaigns.<ref>{{harvnb|Kingston|2010}}</ref>
Breast cancer culture values and honors suffering, selecting its she-roes by a "misery quotient" (Sulik 2010, page 319). ], for example, personifies the breast cancer she-ro. Women whose treatment requires less suffering feel excluded and devalued. The suffering, particularly the extended suffering of months of chemotherapy and radiation treatment, forms a type of ] that initiates women into the inner circle of the breast cancer culture (Ehrenreich 2001).


At the same time, breast cancer culture tends to overlook ] and women who do not fit the white, middle-class archetype. ]s involved with breast cancer organizations often feel like their role is to be the ].<ref>{{harvnb|Sulik|2010|pp=308–309}}</ref>
Mainstream pink ribbon culture is also trivializing, silencing, and infantilizing (Sulik 2010, page 98). Women who choose not to conform to the culture feel excluded and isolated; those who cannot conform to the prescribed triumphant storyline feel unable to share their stories honestly. Anger, negativity and fatalism transgress the feeling rules, and women with breast cancer who express anger or negativity are corrected and disciplined by other women with breast cancer and members of the breast cancer support organizations (Ehrenreich 2001; Sulik 2010, page 240–242). Appearing unattractive—such as going out in public with a bare, bald head if treatment causes temporary hair loss—transgresses the approved, upper-class style of pink femininity and provokes shaming comments from strangers. Women with breast cancer are surrounded by sentimental kitsch and baby toys, such as pink teddy bears, when the equivalent for men, like a blue toy car, is unthinkable (Ehrenreich 2001).


The primary purposes or goals of the breast cancer culture itself are to maintain breast cancer's dominance as the preëminent women's health issue, to promote the appearance that society is "doing something" effective about breast cancer, and to sustain and expand the social, political, and financial power of breast cancer ]s.<ref>{{harvnb|Sulik|2010|p=57}}</ref>
Since the beginning of the 21st century, breast cancer culture has become more sexualized, and many awareness campaigns now reflect the old advertising truism that ]. The "booby campaigns", such as ] and the "I ♥ Boobies" gel bracelets, rely on a cultural obsession with breasts and a market that is already highly aware of breast cancer (Kingston 2010). This message reflects a belief that breast cancer is important not because it kills women prematurely, but because cancer and its treatment makes women feel less sexually desirable and interferes with men's sexual access to women's breasts (Sulik 2010, page 347). These campaigns tend to attract a younger audience than traditional campaigns (Kingston 2010).


The breast cancer culture tells women with breast cancer that their participation in fundraising, social support of other women with breast cancer, and appearance at public events are critical activities that promote their own emotional recovery. Because of this message, some women begin to believe that refusing to raise money for breast cancer organizations or to become mentors for newly diagnosed women with breast cancer is an unhealthy response to breast cancer.<ref>{{harvnb|Sulik|2010|pp=305–311}}</ref>
Breast cancer culture tends to overlook ] and women who do not fit the white, middle-class archetype. ]s involved with breast cancer organizations often feel like their role is to be the ] (Sulik 2010, pages 308–309).


===Feminism and the breast cancer wars===
The primary purposes or goals of breast cancer culture are to maintain breast cancer's dominance as the preëminent women's health issue, to promote the appearance that society is "doing something" effective about breast cancer, and to sustain and expand the social, political, and financial power of breast cancer ]s (Sulik 2010, page 57).
The '''breast cancer wars''' were a series of conflicts between advocates and others about the causes, treatments, and societal responses to breast cancer.<ref>{{harvnb|Olson|2002|pp=192–220}}</ref> Women in the late 1980s and 1990s followed the successful approach used by ] and other AIDS awareness groups, of staging media-friendly protests to increase political pressure. Prominent women who made the "wrong" choice were publicly excoriated, as when ] chose mastectomy over lumpectomy followed by six weeks of ]. The ] was formulated when an early study showed a connection between voluntary ]s and the development of breast cancer in premenopausal women, which pitted breast cancer advocates against abortion rights advocates.<ref>{{harvnb|Olson|2002|pp=192–220}}</ref>


Advocates for women's issues have said that breast cancer is special because of its status as a largely female disease, society's response to it is an ongoing indication of the status of women and the existence of ].<ref>{{harvnb|Olson|2002|pp=195–202}}</ref> Breast cancer activist Virginia Soffa wrote that "s long as it is not a national priority, the breast cancer epidemic will remain a metaphor for how society treats women".<ref>{{harvnb|Soffa|1994|p=208}}</ref> Barbara Ehrenreich writes that, before the feminist movement "medicine was a solid patriarchy", and women with breast cancer were often treated as passive, dependent objects, incapable of making appropriate choices, whose role was to accept whatever treatment was decreed by the physicians and surgeons, who held all of the power.<ref>{{harvnb|Ehrenreich|2001}}</ref> Because of sexism in education, female surgeons were far outnumbered by their male counterparts, and until the 1990s, when ] of the ] Breast Center published ''Dr. Susan Love's Breast Book'', the physicians who provided breast cancer treatments were generally men. Love said that some male physicians tended to impose their own values on women, such as recommending mastectomy to older women because, being past the age of child bearing and breastfeeding, they no longer "needed" their breasts.<ref>{{harvnb|Olson|2002|p=198}}</ref> The ] promoted mutual aid, self-help, ], and an active, informed role in the patient's health care.<ref>{{harvnb|Ehrenreich|2001}}</ref> Since the end of the breast cancer wars, feminists have again objected to the breast cancer culture's treatment of women with breast cancer as little girls who need to be obedient to authority figures, cooperative, pleasant and pretty.<ref>{{harvnb|Ehrenreich|2001}}</ref>
The breast cancer culture tells women with breast cancer that their participation in fundraising, social support other women with breast cancer, and appearance at public events are critical activities that promote their own emotional recovery. Women begin to believe that refusing to raise money for breast cancer organizations or to become mentors for newly diagnosed women with breast cancer is an unhealthy response to breast cancer (Sulik 2010, pages 305–311).


==Feminism and the breast cancer wars== ==Achievements of the breast cancer movement==
Advocates have said that breast cancer is special because society's response to it is an ongoing proof of the status of women and the existence of ] (Olson 2002, pages 195–202; Soffa 1994, page 208). Before the feminist movement, women with breast cancer were often treated as passive, dependent ], incapable of making appropriate choices, whose role was to accept whatever treatment was decreed by the physicians, surgeons, or husbands, who held all of the power (Ehrenreich 2001). Because of sexism in education, few women were trained to be surgeons, and until the 1990s, when ] of the ] Breast Center published ''Dr. Susan Love's Breast Book'', the physicians who provided breast cancer treatments were generally men. Love said that some male physicians tended to impose their own values on women, such as recommending mastectomy to older women because, being past the age of child bearing and breastfeeding, they no longer "needed" their breasts (Olson 2002, page 198). The women's health movement promoted mutual aid, self-help, ], and an active, informed role in the patient's health care (Ehrenreich 2001).


===Social progress===
The '''breast cancer wars''' were a series of conflicts between advocates and others about the causes, treatments, and societal responses to breast cancer (Olson 2002, pages 192–220). Women in the late 1980s and 1990s followed the successful approach used by ] and other ] groups, of staging media-friendly protests to increase political pressure. Prominent women who made the "wrong" choice were publicly excoriated, as when ] chose mastectomy over lumpectomy followed by six weeks of
]. The ] was formulated when an early study showed a connection between voluntary ]s and the development of breast cancer in premenopausal women, which pitted breast cancer advocates against abortion rights advocates (Olson 2002, pages 192–220).


Breast cancer has been known to educated women and caregivers throughout history, but modesty and horror at the consequences of a largely untreatable disease made it a ] subject. The breast cancer movement, which developed in the 1980s and 1990s out of 20th century ] and the women's health movement, has mostly removed those taboos through its modern advocacy and awareness campaigns.<ref>{{harvnb|Sulik|2010|p=4}}</ref>
Since the end of the breast cancer wars, feminists have again objected to the breast cancer culture's treatment of women with breast cancer as little girls who need to be obedient to authority figures, cooperative, pleasant and pretty (Ehrenreich 2001).
====Educated, empowered patients====

At the beginning and middle of the 20th century, breast cancer was usually discussed in hushed tones, as if it were shameful. As an example, '']'' refused to publish an advertisement for a breast cancer support group in the early 1950s, stating that it would not print either the word ''breast'' or the word ''cancer''.<ref>{{harvnb|Mukherjee|2010|pp=26–27}}</ref> Later, however, several celebrities publicly disclosed their own health challenges, and the resulting publicity reduced the stigma.<ref>{{harvnb|Olson|2002|pp=124–144}}</ref> One of the first was ], the former child star, who announced her diagnosis in 1972. In October 1974, ], the wife of the then-President of the United States, openly discussed her breast cancer diagnosis and mastectomy. Two weeks later, the wife of the then-Vice President also had a mastectomy for breast cancer. The next year, journalist ] published her book, ''Breast Cancer: A Personal History and Investigative Report'', which she had written while recovering from a ]. More recently, Angelina Jolie has also come forward publicly regarding her experience surrounding her diagnosis and treatment, which managed to raise public awareness of the issue significantly. In one study, when a survey of women was taken following Jolie's announcement, awareness rose by 4% among those women surveyed.<ref>{{harvnb|Lebo et al.|2015}}</ref> The media reported these women's health and their treatment choices, and even invited some to appear on ]s to discuss breast cancer frankly.<ref>{{harvnb|Olson|2002|pp=124–144}}</ref>
==Achievements of the breast cancer movement==
Breast cancer has been known to educated women and caregivers throughout history, but modesty and horror at the consequences of a largely untreatable disease made it a ] subject. The breast cancer movement, which developed in the 1980s and 1990s out of 20th century ] and the women's health movement, has mostly remove those taboos through its modern advocacy and awareness campaigns (Sulik 2010, page 4).


The breast cancer movement has resulted in widespread acceptance of ]s, the development of less invasive surgical procedures, the spread of ]s, and other advances in patient care.<ref>{{harvnb|Olson|2002|pp=121, 171–220}}</ref> The movement successfully separated ] from mastectomy surgery; before about 1980, it was common to perform the biopsy and, if a quick review of tissues indicated a probable need, a mastectomy in the same surgery.<ref>{{harvnb|Ehrenreich|2001}}; {{harvnb|Olson|2002|pp=168–191}}</ref> The one-step surgery prevented women from seeking different opinions about their treatment, and sent them into the surgery without knowing whether their breasts would be removed that day. In response to women's concerns over ] after routine removal of ] during mastectomy, the more limited approach of ] was developed. Advocacy efforts also led to the formal recommendation against the routine use of the ] in favor of simple mastectomies and lumpectomies.<ref>{{harvnb|Olson|2002|pp=176, 185–186, 250}}</ref>
===Educated, empowered patients===
At the beginning and middle of the 20th century, breast cancer was usually discussed in hushed tones, as if it were shameful (Sulik 2010, page 113). Later, however, several celebrities publicly disclosed their own health challenges, and the resulting publicity reduced the stigma (Olson 2002, pages 124–144). One of the first was ], the former child star, who announced her diagnosis in 1972. In October 1974, ], the wife of the then-President of the United States, openly discussed her breast cancer diagnosis and mastectomy. Two weeks later, the wife of the then-Vice President also had a mastectomy for breast cancer. The next year, journalist ] published her book, ''Breast Cancer: A Personal History and Investigative Report'', which she had written while recovering from a ]. The media reported these women's health and their treatment choices, and even invited some to appear on ]s to discuss breast cancer frankly (Olson 2002, pages 124–144).


The breast cancer movement has supported practical, educational, emotional, and financial care for women with breast cancer. Support groups, individual counseling opportunities, and other resources are made available to patients.
The breast cancer movement has resulted in widespread acceptance of ]s, the development of less invasive surgical procedures, the spread of ]s, and other advances in patient care (Olson 2002, pages 121, 171–220). The movement successfully separated ] from mastectomy surgery; before about 1980, it was common to perform the biopsy and, if a quick review of tissues indicated a probable need, a mastectomy in the same surgery (Ehrenreich 2001; Olson 2002, pages 168–191). The one-step surgery prevented women from seeking different opinions about their treatment, and sent them into the surgery without knowing whether their breasts would be removed that day. In response to women's concerns over ] after routine removal of ] during mastectomy, the more limited approach of ] was developed. Advocacy efforts also led to the formal recommendation against the routine use of the ] in favor of simple mastectomies and lumpectomies (Olson 2002, pages 176, 185–186, 250).


Educational interventions using written material and brief one-to-one interaction about breast checking behaviour, breast cancer symptoms and age-related risk have the potential to increase breast cancer awareness in older women, over a sustained period of time.<ref>{{harvnb|O'Mahony|Comber|Fitzgerald|Corrigan|2017}}</ref>
The breast cancer movement has supported practical, educational, emotional, and financial care for women with breast cancer. Support groups, individual counseling opportunities, and other resources are made available to patients.{{Fact|date=November 2012}}


===Increased resources for treatment and research=== ====Increased resources for treatment and research====
Supporting breast cancer was seen as a distinctively pro-woman stance for public officials to take, without any of the political risks associated with supporting other feminist goals, such as ] or ] (Olson 2002, page 202). This has resulted in better access to care. For example, in much of the United States, low-income women with breast cancer may qualify for taxpayer-funded health care benefits, such as screening mammography, biopsies, or treatment, while women with the same income, but another form of cancer or a medical condition other than cancer, do not.<ref>As an example, the ] pays for breast cancer treatment in women whose of the ], but to be screened or treated for ], ], or ], the income .</ref> Supporting breast cancer detection and treatment was seen as a distinctively pro-woman stance popular among public official. This has resulted in better access to care. For example, in much of the United States, low-income women with breast cancer may qualify for taxpayer-funded health care benefits, such as screening mammography, biopsies, or treatment, while women with the same income, but another form of cancer or a medical condition other than cancer, do not.<ref group="lower-roman">As an example, the ] pays for breast cancer treatment in women whose of the ] (] §371.7), but to be screened or treated for ], ], or ], the income {{webarchive |url=https://web.archive.org/web/20110201064814/http://www.hhsc.state.tx.us/Help/HealthCare/Women/index.html#WHP |date=1 February 2011}}</ref>


Breast cancer advocates have successfully increased the amount of public money being spent on cancer research and shifted the research focus away from other diseases and towards breast cancer. Most breast cancer research is funded by government agencies (Mulholland 2010). Breast cancer advocates also raise millions of dollars for research into cures each year, although most of the funds they raise is spent on screening programs, education and treatment (Ave 2006). Breast cancer advocates have successfully increased the amount of public money being spent on cancer research and shifted the research focus away from other diseases and towards breast cancer.<ref>{{harvnb|Mulholland|2010}}</ref> Breast cancer advocates also raise millions of dollars for research into cures each year, although most of the funds they raise is spent on screening programs, education and treatment.<ref>{{harvnb|Ave|2006}}; {{harvnb|Forman|Gould|Rizzo|2013|pp=7–12}}</ref> Most breast cancer research is funded by government agencies.<ref>{{harvnb|Forman|Gould|Rizzo|2013|pp=7–12}}</ref>


The high level of awareness and organized political lobbying has resulted in a disproportionate level of funding and resources given to breast cancer research and care. Favoring breast cancer with disproportionate research may have the ] of costing lives elsewhere (Browne 2001). In 2001 UK MP ] said, "The treatment has been skewed by the lobbying, there is no doubt about that. Breast cancer sufferers get better treatment in terms of bed spaces, facilities and doctors and nurses" (Browne 2001). The high level of awareness and organized political lobbying has resulted in a disproportionate level of funding and resources given to breast cancer research and care. Favoring breast cancer with disproportionate research may have the ] of costing lives elsewhere.<ref>{{harvnb|Browne|2001}}</ref> In 2001 UK MP ] said, "The treatment has been skewed by the lobbying, there is no doubt about that. Breast cancer sufferers get better treatment in terms of bed spaces, facilities and doctors and nurses".<ref>{{harvnb|Browne|2001}}</ref>


==Risks of too much awareness== ==Risks of over-awareness==
{{pie chart {{pie chart
| title = Causes of death
| caption=Women are far more likely to die from heart disease or stroke than from breast cancer
| caption='''Causes of death among women''': Breast cancer is the cause of death of 2% of women. <br /><small>Source: WHO (2004){{#tag:ref|Grouped by cause {{harvnb|World Health Organization|2004|p=120}}|group=lower-roman}}</small>
| other = yes | other = yes
| label1 = Deaths from breast cancer | label1 = Deaths from ]
| value1 = 2 | color1 = pink | value1 = 2 | color1 = pink
| label2 = Deaths from heart disease or stroke | label2 = Deaths from ] or ]
| value2 = 32 | color2 = red | value2 = 32 | color2 = red
| label3 = Deaths from other cancers | label3 = Deaths from other ]s
| value3 = 10 | color3 = purple | value3 = 10 | color3 = purple
| label4 = Deaths from lung diseases
| value4 = 7 | color4 = gray
| label5 = Deaths from injuries
| value5 = 6 | color5 = orange
| label6 = Deaths from digestive diseases
| value6 = 3 | color6 = brown
| label7 = Deaths from neuropsychiatric disorders
| value7 = 5 | color7 = green
}} }}


Awareness has also led to increased anxiety for women. Early detection efforts result in overdiagnosis of precancerous and cancerous tumors that would never risk the woman's life (about one-third of breast cancers diagnosed through screening programs), and result in her being subjected to invasive and sometimes dangerous radiological and surgical procedures.<ref>{{harvnb|Aschwanden|2009}}</ref>
Because breast cancer is a highly visible disease, most women significantly overestimate their personal risk of dying from it. Misleading statistics, such as the claim that one in eight women will be diagnosed with breast cancer during their lives—a claim that depends on the patently unrealistic assumption that no woman will die of any other disease before the age of 95 (Olson 2002, pages 199–200)—obscure the reality, which is that about ten times as many women will die from ] or ] than from breast cancer (Ave 2006).


In recent years, the definition of breast cancer has expanded to include non-invasive, non-cancerous conditions like ] (LCIS) and pre-cancerous or "stage 0" conditions like ] (DCIS). Despite the now-regretted decision to use the word ''carcinoma'' in these relatively common conditions (almost a quarter of "breast cancer" diagnoses in the US), they are not life-threatening ]s.<ref>{{harvnb|Sulik|2010|pp=165–171}}</ref> Women with these conditions are promoted as breast cancer survivors due to the fear they experienced before they became educated about their condition, rather than in respect of any real threat to their lives. This effectively increases the ] for breast cancer organizations, medical establishments, pharmaceutical manufacturers, and the makers of mammography equipment.<ref>{{harvnb|Sulik|2010|pp=170–171}}</ref>
Awareness has also led to increased anxiety for women. Early detection efforts result in overdiagnosis of precancerous and cancerous tumors that would never risk the woman's life (about one-third of breast cancers), and result in her being subjected to invasive and sometimes dangerous radiological and surgical procedures (Aschwanden 2009).


Women fear dying from breast cancer more than dying from ], even though, as of 2006, eleven times as many women died from heart disease and stroke as from breast cancer.<ref>{{harvnb|Ave|2006}}</ref> According to cardiologist Lisa Rosenbaum, this may be because women "view heart disease as the consequence of having done something bad, whereas to get breast cancer is to have something bad happen to you".<ref>{{harvnb|Rosenbaum|2014}}</ref>
The breast cancer culture has also promoted an expansive definition of breast cancer, which includes non-invasive, non-cancerous conditions like ] (LCIS) and pre-cancerous or "stage 0" conditions like ] (DCIS). Despite the now-regretted decision to use the word ''carcinoma'' in these relatively common conditions (almost a quarter of "breast cancer" diagnoses in the USA), they are not life-threatening ]s (Sulik 2010, page 165–171). Women with these conditions are promoted as breast cancer survivors due to the fear they experienced before they became educated about their condition, rather than in respect of any real threat to their lives. This effectively increases the ] for breast cancer organizations, medical establishments, pharmaceutical manufacturers, and the makers of mammography equipment (Sulik 2010, page 170–171).


An emphasis on educating women about lifestyle changes that may have a small impact on preventing breast cancer often makes women feel guilty if they do develop breast cancer. Some women decide that their own cancer resulted from poor diet, lack of exercise, or other modifiable lifestyle factor, even though most cases of breast cancer are due to non-controllable factors, like genetics or naturally occurring background radiation. Adopting such a belief may increase their sense of being ] of their fate. Increased awareness inadvertently increases ] (Olson 2002, pages 240–242, Sulik 2010, page 74, 263). Women who resist screening mammography or ]s are subjected to social pressure, scare tactics, guilt, and threats from some physicians to terminate the ] (Welch 2010). Similarly, the emphasis on early detection results in women blaming themselves if their cancer is not detected at an early stage. An emphasis on educating women about lifestyle changes that may have a small impact on preventing breast cancer often makes women feel guilty if they do develop breast cancer. Some women decide that their own cancer resulted from poor diet, lack of exercise, or other modifiable lifestyle factor, even though most cases of breast cancer are due to non-controllable factors, like genetics or naturally occurring background radiation. Adopting such a belief may increase their sense of being ] of their fate. Increased awareness inadvertently increases ].<ref>{{harvnb|Olson|2002|pp = 240–242}}; {{harvnb|Sulik|2010|pp = 74, 263}}</ref> Women who resist screening mammography or ]s are subjected to social pressure, scare tactics, guilt, and threats from some physicians to terminate the ].<ref>{{harvnb|Welch|2010}}</ref> Similarly, the emphasis on early detection results in many women wrongly blaming themselves if their cancer is not detected at an early stage.


The promotion of research to make screening programs find ever more cancers is also criticized. One-third of diagnosed breast cancers might recede on their own (Aschwanden 2009). Screening mammography efficiently finds non-life-threatening, asymptomatic breast cancers and pre-cancers, even while overlooking serious cancers.<!-- Yes, the WHOLE PARAGRAPH is supported by the SAME SOURCE --> According to H. Gilbert Welch of the Dartmouth Institute for Health Policy and Clinical Practice, research on screening mammography has taken the "brain-dead approach that says the best test is the one that finds the most cancers" rather than the one that finds dangerous cancers (Aschwanden 2009). The promotion of research to make screening programs find ever more cancers is also criticized. One-third of diagnosed breast cancers might recede on their own.<ref>{{harvnb|Aschwanden|2009}}</ref> In addition to efficiently finding most deadly cancers, screening programs also find most non-life-threatening, asymptomatic breast cancers and pre-cancers, and miss some fast growing, aggressive, dangerous cancers. According to H. Gilbert Welch of the Dartmouth Institute for Health Policy and Clinical Practice, "I'm certainly not asking anyone to stop getting mammograms. I am asking my profession to tell women the truth about ]".<ref>{{harvnb|Beck|2012}}</ref> Welch said that research on screening mammography has taken the "brain-dead approach that says the best test is the one that finds the most cancers" rather than the one that finds dangerous cancers.<ref>{{harvnb|Aschwanden|2009}}</ref>


Clinicians have responded that they are unwilling to consider the possibility of leaving potential deadly cancers alone because it is "far-riskier" than the alternative. ], director of the breast cancer program at Dana-Farber Cancer Institute in Boston, says, "I don't know anyone who offers women the option of doing nothing".<ref>{{harvnb|Beck|2012}}</ref> Further complicating the issue of early diagnosis is the fact that it is currently impossible to distinguish malicious cancers from benign ones. Otis Brawley, a top official for the American Cancer Society, says that "even if we overdiagnose 1 in 5, we have numerous studies showing that by treating all these women, we save a bunch of lives". For instance, a 2011 Cochrane review showed a sample of mammogram screening programs resulted in a 15% reduction in mortality rate despite over-diagnosis, indicating that mammography programs save lives regardless of over-diagnosis.<ref>{{harvnb|Beck|2012}}</ref>
==Independence of breast cancer organizations==
Some critics say that breast cancer awareness has transformed the disease into a market-driven industry of survivorship and corporate sales pitches (Ave 2006; King 2006). Corporate marketing machines promote early detection of breast cancer, while also opposing public health efforts, such as stricter environmental legislation, that might prevent the disease entirely. These critics believe that some of the breast cancer organizations, particularly the highly visible Susan G. Komen for the Cure, have become ] that support and provide ] to the breast cancer industry, including ], mammography equipment manufacturers, and pollution-causing industries, as well as large corporations, creating or exacerbating other problems.


==Conflicts of interest in organizations==
For example, ] ran a "Warriors in Pink" promotion on their ] sports car, which critics say was intended to sell cars and counter the bad publicity the company received by reducing its workforce by tens of thousands of people, causing many of them to lose their ], rather than to prevent or cure breast cancer (Sulik 2010, page 130-135).
Some critics say that breast cancer awareness has transformed the disease into a market-driven industry of survivorship and corporate sales pitches.<ref>{{harvnb|Ave|2006}}; {{harvnb|King|2006}}</ref> Corporate marketing machines promote early detection of breast cancer, while also opposing public health efforts, such as stricter environmental legislation, that might decrease the incidence rate of breast cancer. These critics believe that some of the breast cancer organizations, particularly the highly visible Susan G. Komen for the Cure, have become ] that support and provide ] to the '''breast cancer industry''', including ], mammography equipment manufacturers, and pollution-causing industries, as well as large corporations, creating or exacerbating other problems.<ref>{{harvnb|Sulik|2010|pp=160–210}}</ref>


For example, ] ran a "Warriors in Pink" promotion on their ] sports car, which critics say was intended to sell cars and counter the bad publicity the company received by reducing its workforce by tens of thousands of people, causing many of them to lose their ], rather than to prevent or cure breast cancer.<ref>{{harvnb|Sulik|2010|pp=130–135}}</ref> A Ford spokesperson acknowledged that the objective of the promotion was to "do good works throughout the community and derive some marketing exposure at the same time", but said that over the promotion's 15 years the company had donated $100 million and that the company continued the program during the ] because "It's part of our DNA now." Ford believes that the recipient of the funds, Susan G. Komen for the Cure, benefited because Ford helped it reach "people who might not have thought of this organization before or may be supporting other organizations".<ref>{{harvnb|Elliott|2009}}</ref>
However, the primary sponsors are part of the breast cancer industry, particularly cancer drug makers like AstraZeneca, Bristol-Myers Squibb, and Novartis. Because the national breast cancer organizations are dependent on ]s for survival, this situation may represent a ] that prevents these organizations from representing the needs of current and future people with breast cancer when those needs conflict with the profit-making motives of the corporate sponsors. To avoid offending sponsors or to woo new ones, breast cancer organizations may self-censor their message and oversell options like screening mammography and new chemotherapeutic agents (Sulik 2010, page 209–210).


However, the primary sponsors are part of the breast cancer industry, particularly cancer drug makers like AstraZeneca, Bristol-Myers Squibb, and Novartis. Because the national breast cancer organizations are dependent on ]s for survival, this situation may represent a conflict of interest that prevents these organizations from representing the needs of current and future people with breast cancer when those needs conflict with the profit-making motives of the corporate sponsors.<ref>{{harvnb|Sulik|2010|pp=209–210}}</ref>
The structure of the breast cancer movement may allow large organizations to claim to be the voice of women with breast cancer, while simultaneously ignoring their desires (Sulik 2010, page 376).


The structure of the breast cancer movement may allow large organizations to claim to be the voice of women with breast cancer, while simultaneously ignoring their desires.<ref>{{harvnb|Sulik|2010|p=376}}</ref>
Some breast cancer organizations, such as ], refuse to accept funds from medical or other companies they disapprove of.

Some breast cancer organizations, such as Breast Cancer Action, refuse to accept funds from medical or other companies they disapprove of.<ref>{{harvnb|Sargeant|2014|pp=271–213}}</ref>


==Environmental breast cancer movement== ==Environmental breast cancer movement==
Most of the money raised by advocates is spent on advertising, increased awareness, ], and existing treatments (Ave 2006). Only a small fraction of the funds is spent on research, and most of that funding is spent on research to improve diagnosis and treatment of breast cancer. To the dismay of advocates like ] and women's health issues scholar Samantha King, relatively little money or attention is devoted to identifying the non-genetic causes of breast cancer or taking steps to prevent breast cancer from occurring (Ave 2006). The mainstream breast cancer culture is focused on a cure for existing breast cancer cases, rather than on preventing future cases.


Most of the money raised by advocates is spent on increasing awareness, ], and existing treatments.<ref>{{harvnb|Ave|2006}}</ref> Only a small fraction of the funds is spent on research, and less than 7% of the total research funding provided by breast cancer organizations goes to prevention.<ref>{{harvnb|Forman|Gould|Rizzo|2013|pp=7–12}}</ref> Instead, most of the charities fund research into detection and treatment.<ref>{{harvnb|Forman|Gould|Rizzo|2013|pp=7–12}}</ref> Advocates like Breast Cancer Action and women's health issues scholar Samantha King, whose book inspired the 2011 documentary '']'', are unhappy that relatively little money or attention is devoted to identifying the non-genetic causes of breast cancer or to preventing breast cancer from occurring.<ref>{{harvnb|Ave|2006}}</ref> The mainstream breast cancer culture has been criticized for focusing on detecting and curing existing breast cancer cases, rather than on preventing future cases.<ref>{{harvnb|Ave|2006}}; {{harvnb|King|2006|p=38}}</ref>
As a result, screening mammography is promoted by the breast cancer industry as the sole possible approach to ] for breast cancer (Sulik 2010, page 204). Alternatives, such as pollution prevention, are largely ignored.


As a result, screening mammography is promoted by the breast cancer culture as the sole possible approach to ] for breast cancer.<ref>{{harvnb|Sulik|2010|p=204}}</ref> Alternatives, such as pollution prevention, are largely ignored.<ref>{{harvnb|King|2006|p=38}}</ref>
As the majority of women with breast cancer have no risk factors other than sex and age, the '''environmental breast cancer movement''' suspects pollution as a significant cause, possibly from pesticides, plastics, or petroleum products (Ehrenreich 2001). The largest organizations, particularly Susan G. Komen for the Cure and the American Cancer Society, are not part of the environmental breast cancer movement (Ehrenreich 2001). These organizations benefit the most from corporate sponsorships that critics deride as pinkwashing, e.g., polluting industries trying to buy public goodwill by publishing advertisements emblazoned with pink ribbons, rather than stopping their pollution under the ] (King 2006, pages 1–2).


As the majority of women with breast cancer have no risk factors other than sex and age, the '''environmental breast cancer movement''' suspects pollution as a significant cause, possibly from pesticides, plastics, and industrial runoff in ground water.<ref>{{harvnb|Ehrenreich|2001}}</ref> Large organizations, such as Susan G. Komen for the Cure and the American Cancer Society, are not part of the environmental breast cancer movement.<ref>{{harvnb|Ehrenreich|2001}}</ref> These large organizations benefit the most from corporate sponsorships that critics deride as ''pinkwashing'', e.g., polluting industries trying to buy public goodwill by publishing advertisements emblazoned with pink ribbons, rather than stopping their pollution under the ].<ref>{{harvnb|King |2006|pp=vii–xxv, 1–28}}; {{harvnb|Sulik|2010|pp=55–56, 188–189}}</ref>
Samantha King says that prevention research is minimized by the breast cancer industry because there is no way to make money off of cases of breast cancer that do not happen, whereas a mammography imaging system that finds more possible cancers, or a "magic bullet" that kills confirmed cancers, would be highly profitable (King 2006, page 38). This prejudice applies equally to breast cancer organizations, because a reliable form of prevention would deplete their future supply of dedicated volunteers.


The non-genetic factors with consistent evidence increasing breast cancer risk include "], combination ], and greater postmenopausal weight.&nbsp;... for many other factors, the evidence from human studies is more limited, contradictory, or absent" and called for additional research.<ref>{{harvnb|Institute of Medicine|2012}}</ref> Conducting research into whether a chemical causes cancer is difficult, because "suspect chemicals cannot ethically be given to people to see if they cause cancer. People exposed in the past can be studied, but information about the dose and timing may be sketchy. Animal studies can provide useful information, but do not always apply to humans. And people are often exposed to mixtures of chemicals that may interact in complex ways, with effects that may also vary depending on an individual's genetic makeup".<ref>{{harvnb|Grady|2011}}</ref>
==Dissent through art==
While the pink ribbon culture is dominant, cracks in the façade of unity show through. The environmental breast cancer movement is one type of dissent. Another is the rejection of compliant optimism, aesthetic normalization, and social pleasingness that the pink ribbon culture promotes (Sulik 2010, pages 229–377).


Samantha King says that prevention research is minimized by the breast cancer industry because there is no way to make money off of cases of breast cancer that do not happen, whereas a mammography imaging system that finds more possible cancers, or a "magic bullet" that kills confirmed cancers, would be highly profitable.<ref>{{harvnb|King|2006|p=38}}</ref>
In 1998, the Art.Rage.Us art collective published a book that collected some of the art work from their traveling collection. This included art that was shocking, painful and realistic rather than beautiful, such as several self-portraits that showed mastectomy scars (Sulik 2010, pages 326–332).


===Breast Cancer Action===
Another art form has a wider range: the ] has become a staple of breast cancer literature. This may take the form of a restitution or ] (the protagonist seeks a physical or spiritual return to a pre-diagnosis life), a ] (the protagonist must meet a goal before dying), or a ] (the situation inexorably goes from bad to worse). The cure and quest narratives fit neatly with the breast cancer culture. Chaos narratives, rarer with breast cancer, oppose it (Sulik 2010, pages 321–326).
{{Main|Breast Cancer Action}}
Breast Cancer Action is an American ] education and ] organization that promotes breast cancer awareness and ] issues relating to breast cancer, and advocates for system-wide change based on prevention. Breast Cancer Action is also known for its ''Think Before You Pink'' campaign, launched in 2002, which encourages consumers to ask critical questions before buying ] products.<ref>{{harvnb|Levine|2005}}</ref>


==Dissent through art==
==History==
While the pink ribbon culture is dominant, there are alternatives. The environmental breast cancer movement is one type of dissent. Another is the rejection of compliant optimism, aesthetic normalization, and social pleasingness that the pink ribbon culture promotes.<ref>{{harvnb|Sulik|2010|pp=229–377}}</ref><!--This is a three-sentence summary of an entire section of the book. The long page range is correct.-->
Breast cancer has been known and feared since ancient times. With no reliable treatments, and with surgical outcomes often fatal, women tended to conceal the possibility of breast cancer as long as possible. With the dramatic improvement in survival rates at the end of the 19th century—the radical mastectomy promoted by William Stewart Halsted raised long-term survival rates from 10% to 50%—efforts to educate women about the importance of early detection and prompt action were begun (Olson 2002, page 1; King 2006, page xix).


In 1998, the Art.Rage.Us art collective published a book that collected some of the art work from their traveling collection. This included art that was shocking, painful and realistic rather than beautiful, such as several self-portraits that showed mastectomy scars.<ref>{{harvnb|Sulik|2010|pp=326–332}}</ref>
Early campaigns included the "Women's Field Army", run by the ] (the forerunner of the ]) during the 1930s and 1940s. Explicitly using a military metaphor, they promoted early detection and prompt medical intervention as every woman's duty in the war on cancer. In 1952, the first peer-to-peer support group, called ], was formed. Later taken over by the American Cancer Society, it provided post-mastectomy, in-hospital visits from women who had survived breast cancer, who shared their own experiences, practical advice, and emotional support, but never medical information. This was the first program designed to promote restoration of a feminine appearance, e.g., through providing ], as a goal (Sulik 2010, pages 37–38).


Another art form has a wider range: the ] has become a staple of breast cancer literature and is prominent in women's magazines. This may take the form of a restitution or ] (the protagonist seeks a physical or spiritual return to a pre-diagnosis life), a ] (the protagonist must meet a goal before dying), or a ] (the situation inexorably goes from bad to worse). The cure and quest narratives fit neatly with the breast cancer culture. Chaos narratives, which are rarer in stories about breast cancer, oppose it.<ref>{{harvnb|Sulik|2010|pp=321–326}}</ref>
==Organizations==
<!--


==History==
Please!
], responsible for the ] that dramatically reduced death rates due to breast cancer, but later proved to be controversial in its own right.]]


Breast cancer has been known since ancient times. With no reliable treatments, and with surgical outcomes often fatal, women tended to conceal the possibility of breast cancer as long as possible. With the dramatic improvement in survival rates at the end of the 19th century—the radical mastectomy promoted by William Stewart Halsted raised long-term survival rates from 10% to 50%—efforts to educate women about the importance of early detection and prompt action were begun.<ref>{{harvnb|Olson|2002|p=1}}; {{harvnb|King|2006|p=xix}}</ref>
The goal is to name the biggest and most historically important organizations, not to advertise your local group.


Early campaigns included the "Women's Field Army", run by the American Society for the Control of Cancer (the forerunner of the American Cancer Society) during the 1930s and 1940s. Explicitly using a military metaphor, they promoted early detection and prompt medical intervention as every woman's duty in the war on cancer. In 1952, the first peer-to-peer support group, called Reach to Recovery, was formed. Later taken over by the American Cancer Society, it provided post-mastectomy, in-hospital visits from women who had survived breast cancer, who shared their own experiences, practical advice, and emotional support, but never medical information. This was the first program designed to promote restoration of a feminine appearance, e.g., through providing ], as a goal.<ref>{{harvnb|Sulik|2010|pp=37–38}}</ref>
-->

A wide variety of charitable organizations are involved in breast cancer awareness and support. These organizations do everything from providing practical support, to educating the public, to dispensing millions of dollars for research and treatment. Thousands of small breast cancer organizations exist. The most largest and prominent are:
==Organizations==


A wide variety of charitable organizations are involved in breast cancer awareness and support. These organizations do everything from providing practical support, to educating the public, to dispensing millions of dollars for research and treatment. Thousands of small breast cancer organizations exist. The largest and most prominent are:
* ]: Komen is the largest and best funded organization, with highly visible fundraisers. They represent the good, hopeful, happy, unified survivors who have embraced pink ribbon culture.
* ]: Komen is the largest and best funded organization, with highly visible fundraisers.
* ]: This large umbrella organization played key roles in several prominent pieces of American legislation, such as the creation of the ]'s Breast Cancer Research Program, genetic non-discrimination laws, and the patients' bill of rights. They are committed to ]. * ]: This large umbrella organization played key roles in several prominent pieces of American legislation, such as the creation of the ]'s Breast Cancer Research Program, genetic non-discrimination laws, and the patients' bill of rights. They are committed to ].
* ]: Famous for its "Think Before You Pink" campaign against ], BCA emphasizes the need for research into pollution as a cause of breast cancer. Like the ], they refuse funding from any group that may have a ], such as pharmaceutical companies, medical imaging companies, or pollution-causing industries. * ]: Famous for its "Think Before You Pink" campaign against ], BCA emphasizes the need for research into pollution as a cause of breast cancer.<ref>{{harvnb|Levine|2005}}</ref> Like the ], they refuse funding from any group that may have a ], such as pharmaceutical companies, medical imaging companies, or pollution-causing industries.
* National Breast Cancer Organization: Closed in 2004. A dissenter to the notion of mandatory public unity, it provided ] and other services. * National Breast Cancer Organization: Closed in 2004. A dissenter to the notion of mandatory public unity, it provided ] and other services.
* ]
* New York State Breast Cancer Support and Education Network (US): An association of groups in New York that are not affiliated with Komen, they are committed to evidence-based medicine rather than conventional wisdom.
* ]: Like Breast Cancer Action, they are a key player in the environmental breast cancer movement.

While the large organizations dominate the media, most of the practical, day-to-day support for women with breast cancer is provided by small, local groups. While providing the bulk of unglamorous, practical assistance, like driving women to and from medical appointments, these organizations typically struggle for funding in the shadow of the large groups (Sulik 2010, page 53).


==See also== ==See also==
* ] * ]
* ] * ]
* ]
* ]


==Notes== ==Footnotes==
{{Reflist|group=lower-roman}}
{{reflist}}


==References== ==References==
{{reflist}}

==Sources==
* {{cite news * {{cite news
| title= A Gender Gap in Cancer | title = A Gender Gap in Cancer
| date= 13 June 2007 | date = 13 June 2007
| author= Arnst, Catherine | last = Arnst
| journal= ] | first = Catherine
| journal = ]
| url = http://www.businessweek.com/technology/content/jun2007/tc20070612_953676.htm
| issn= 0007-7135
| url= http://www.businessweek.com/technology/content/jun2007/tc20070612_953676.htm }} | archive-url = https://web.archive.org/web/20070616064149/http://www.businessweek.com/technology/content/jun2007/tc20070612_953676.htm
| url-status = dead
| archive-date = 16 June 2007
}}
* {{cite news * {{cite news
| title= The Trouble with Mammograms | title = The Trouble with Mammograms
| date= 17 August 2009 | date = 17 August 2009
| author= Aschwanden, Christie | last = Aschwanden
| first = Christie
| newspaper= ]
| author-link = Christie Aschwanden
| issn = 0458-3035
| newspaper =]
| url= http://articles.latimes.com/2009/aug/17/health/he-breast-overdiagnosis17 }}
| url= https://www.latimes.com/archives/la-xpm-2009-aug-17-he-breast-overdiagnosis17-story.html
}}
* {{cite news |last=Ave |first=Melanie |title=All May Not Be in the Pink |journal=] |date=10 October 2006 |url=https://www.tampabay.com/archive/2006/10/07/all-may-not-be-in-the-pink/}}
* {{cite news * {{cite news
| title = Can There Be Too Much Breast-Cancer Treatment?
| author= Ave, Melanie
| last = Beck
| title= Tampabay: All May Not Be in the Pink
| first = Melinda
| journal= ]
| newspaper = ]
| date= 10 October 2006
| date = 4 September 2012
| issn = 1563-6291
| url= http://www.sptimes.com/2006/10/06/Tampabay/All_may_not_be_in_the.shtml }} | url= https://www.wsj.com/articles/SB10000872396390444914904577623522202606392
}}
* {{cite news | last = Borrelli | first = Christopher | title = Click. Support. Whatever. Social network campaigns build 'slacktivism' to new heights, but is there real impact behind these digital devotions? | work = ] | url = http://articles.chicagotribune.com/2010-06-01/entertainment/ct-live-0601-slacktivism-20100601_1_facebook-pages-conan-o-brien-slacktivism | date = 2010-06-01 | accessdate = 2012-11-24 }}
* {{cite news * {{cite news
| last = Borrelli
| url=http://www.guardian.co.uk/society/2001/oct/07/cancercare
| first = Christopher
| location=London
| title = Click. Support. Whatever. Social network campaigns build 'slacktivism' to new heights, but is there real impact behind these digital devotions?
| journal= ]
| work = ]
| first=Anthony
| url = https://www.chicagotribune.com/2010/06/01/click-support-whatever/
| last=Browne
| date = 1 June 2010
| title=Cancer Bias Puts Breasts First
}}
* {{cite news
| url = https://www.theguardian.com/society/2001/oct/07/cancercare
| location = London
| journal =]
| first = Anthony
| last= Browne
| title = Cancer Bias Puts Breasts First
| issn = 0261-3077 | issn = 0261-3077
| date=7 October 2001}} | date=7 October 2001
}}
* {{Cite news|last=Burns|first=Holly|date=2021-10-15|title=For Some Breast Cancer Survivors, October Is the Cruelest Month|language=en-US|work=]|url=https://www.nytimes.com/2021/10/15/well/live/breast-cancer-awareness-month-anxiety.html|issn=0362-4331}}
* {{cite news
| last = Elliott
| first = Stuart
| title = For Causes, It's a Tougher Sell
| newspaper = The New York Times
| date = 12 November 2009
| page = F1
| url= https://query.nytimes.com/gst/fullpage.html?res=9C06E6DC163DF931A25752C1A96F9C8B63
}}
* {{Cite news * {{Cite news
| first = Barbara |first=Barbara
| last = Ehrenreich |last=Ehrenreich
| authorlink = Barbara Ehrenreich |author-link=Barbara Ehrenreich
| title = Welcome to Cancerland |title=Welcome to Cancerland
| newspaper = ] |newspaper=]
| date = November 2001 |date=November 2001
|url=http://www.barbaraehrenreich.com/cancerland.htm
| issn = 0017-789X
|url-status=dead
| url = http://www.barbaraehrenreich.com/cancerland.htm }}
|archive-url=https://web.archive.org/web/20110609202708/http://www.barbaraehrenreich.com/cancerland.htm
|archive-date=9 June 2011
}}
* {{cite report
| title=Breast Cancer and the Environment: Prioritizing Prevention
| last1=Forman
| first1=Michelle R.
| last2=Gould
|first2=Michael N.
|last3=Rizzo
|first3=Jeanne
| url=http://www.niehs.nih.gov/about/assets/docs/ibcercc_full_508.pdf
| publisher=Interagency Breast Cancer and Environmental Research Coordinating Committee (IBCERCC)
| date=February 2013
}}
* {{cite news
| last = Grady
| first = Denise
| title = Panel Finds Few Clear Environmental Links to Breast Cancer
| newspaper = The New York Times
| date = 8 December 2011
| page = A3
| url = https://www.nytimes.com/2011/12/08/health/scientific-panel-finds-few-clear-environmental-links-to-breast-cancer.html
}}
* {{Cite news |last=Gustines |first=George Gene |date=2010-10-03 |title=Comic Strips Think Pink |language=en-US |work=The New York Times |url=https://www.nytimes.com/2010/10/04/arts/04arts-COMICSTRIPST_BRF.html |access-date=2023-07-08 |issn=0362-4331}}
* {{cite book
| author=Institute of Medicine
| title=Breast Cancer and the Environment: A Life Course Approach (Institute of Medicine)
| publisher=National Academies Press
| location=Washington, D.C
| year=2012
| isbn=978-0-309-22069-9
}}
* {{cite book * {{cite book
| author= King, Samantha | last= King
| first= Samantha
| title= Pink Ribbons, Inc.: Breast Cancer and the Politics of Philanthropy | url = http://books.google.ca/books?id=_JvEpEYFj_gC
| title= Pink Ribbons, Inc.: Breast Cancer and the Politics of Philanthropy
| url = https://books.google.com/books?id=_JvEpEYFj_gC
| publisher= ] | publisher= ]
| location= Minneapolis | location= Minneapolis
| year= 2006 | year= 2006
| isbn= 0-8166-4898-0 }} | isbn= 978-0-8166-4898-6
}}
* {{cite news * {{cite news
| author = Kingston, Anne | last = Kingston
| first= Anne
| year = 2010 | year = 2010
| title = A Nice Rack of Slogans | title = A Nice Rack of Slogans
| journal = ] | journal = ]
| issn = 0024-9262
| volume = 123 | volume = 123
| number = 41 | number = 41
| page = 73 }} | page = 73
}}
* {{Cite web * {{Cite web
| author = Landman, Anne | last = Landman
| first= Anne
| date = 11 June 2008 | date = 11 June 2008
| url = http://www.prwatch.org/node/7436 | url = http://www.prwatch.org/node/7436
| work = ] | work = ]
| title = Pinkwashing: Can Shopping Cure Breast Cancer? | title = Pinkwashing: Can Shopping Cure Breast Cancer?
| publisher = ]}} | publisher = ]
}}
* {{Cite journal
|last1=Lebo
|first1=Patricia Beatrice
|last2=Quehenberger
|first2=Franz
|last3=Kamolz
|first3=Lars-Peter
|last4=Lumenta
|date=2015-11-15
|title=The Angelina effect revisited: Exploring a media-related impact on public awareness
|journal=Cancer
|volume=121
|issue=22
|pages=3959–3964
|doi=10.1002/cncr.29461
|pmid=26414603
|issn=1097-0142
|ref = {{harvid|Lebo et al.|2015}}
|doi-access=free
}}
* {{Cite news * {{Cite news
| last = Levine | last = Levine
Line 295: Line 368:
| date = 30 September 2005 | date = 30 September 2005
| issn = 0890-0337 | issn = 0890-0337
| url = http://sanfrancisco.bizjournals.com/sanfrancisco/stories/2005/10/03/newscolumn5.html }} | url = http://sanfrancisco.bizjournals.com/sanfrancisco/stories/2005/10/03/newscolumn5.html
}}
* {{cite news
| first = Carpenter
| last = Mackenzie
| date = October 1 2006
| url = http://www.post-gazette.com/stories/sectionfront/life/just-about-everything-turns-pink-for-cancer-in-october-452768/
| title = Just about everything turns pink for cancer in October
| work = ]}}
* {{cite web * {{cite web
| url=http://www.mint.ca/store/mint/learn/breast-cancer-coin-2006-1600008 | url=http://www.mint.ca/store/mint/learn/breast-cancer-coin-2006-1600008
Line 308: Line 375:
| publisher=] | publisher=]
| year = 2006 | year = 2006
| accessdate=12 November 2010}} | access-date=12 November 2010
| ref = {{sfnref|Royal Canadian Mint|2006}}}}
* {{Cite book |last=Moore |first=Sarah E. H. |title=Ribbon Culture: Charity, Compassion and Public Awareness |publisher=Palgrave Macmillan UK |year=2008 |isbn=9780230583382 |location=United Kingdom |language=en}}
* {{cite book
|last=Mukherjee|first=Siddhartha
|title=The Emperor of All Maladies: A Biography of Cancer
|year=2010
|publisher=Scribner |location=New York
|isbn=978-1439181713|edition=1st Scribner hardcover
|title-link=The Emperor of All Maladies: A Biography of Cancer
}}
* {{cite news * {{cite news
| title= Breast Cancer Month Overshadowed by 'Pinkwashing' | title= Breast Cancer Month Overshadowed by 'Pinkwashing'
| date= 9 October 2010 | date= 9 October 2010
| author= Mulholland, Angela | last= Mulholland
| first= Angela
| publisher= CTV.ca News | publisher= CTV.ca News
| url= https://www.ctvnews.ca/breast-cancer-month-overshadowed-by-pinkwashing-1.561275
| url= http://ottawa.ctv.ca/servlet/an/local/CTVNews/20101008/pinkwashing-pink-ribbon-101009/20101009/?hub=OttawaHome }}
}}
* {{Cite journal
| last1=O'Mahony | first1=Máirín
| last2=Comber | first2=Harry
| last3=Fitzgerald | first3=Tony
| last4=Corrigan | first4=Mark A
| last5=Fitzgerald | first5=Eileen
| last6=Grunfeld | first6=Elizabeth A
| last7=Flynn | first7=Maura G
| last8=Hegarty | first8=Josephine
| date=10 February 2017
| title=Interventions for Raising Breast Cancer Awareness in Women
| journal=Cochrane Database of Systematic Reviews
| volume=2017 | issue=2
| pages=CD011396
| doi=10.1002/14651858.cd011396.pub2 | issn=1465-1858 | pmc=6464597 | pmid=28185268
}}
* {{cite book * {{cite book
| last=Olson
| author=Olson, James Stuart | url = http://books.google.ca/books?id=gp9aMBieClMC
| first=James Stuart
| url = https://books.google.com/books?id=gp9aMBieClMC
| title=Bathsheba's Breast: Women, Cancer and History | title=Bathsheba's Breast: Women, Cancer and History
| publisher= ] | publisher= ]
Line 322: Line 419:
| year=2002 | year=2002
| oclc = 186453370 | oclc = 186453370
| isbn=0-8018-6936-6 }} | isbn=978-0-8018-6936-5
}}
* {{cite journal
| last=Rosenbaum
| first=Lisa
| title="Misfearing"—Culture, Identity, and Our Perceptions of Health Risks
| journal=New England Journal of Medicine
| volume=370
| issue=7
| pages=595–7
|date=February 2014
| pmid=24521105
| doi=10.1056/NEJMp1314638
}}
* {{Cite book
| last=Sargeant
| first=Adrian
| url=https://books.google.com/books?id=lhIWBAAAQBAJ&dq=%22breast+cancer%22+%22conflict+of+interest%22+donations&pg=PA271
| title=Fundraising Management: Analysis, Planning and Practice
| date=2014-07-30 |publisher=Routledge
| isbn=978-1-134-61992-4
| language=en}}
* {{cite news
| last=Singer
| first=Natasha
| title=Welcome, Fans, to the Pinking of America
| newspaper=The New York Times
| date=16 October 2011
| page=BU1
| url=https://www.nytimes.com/2011/10/16/business/in-the-breast-cancer-fight-the-pinking-of-america.html?pagewanted=all
}}
* {{cite book * {{cite book
| author=Soffa, Virginia M. | last=Soffa
| first=Virginia M.
| title=The Journey Beyond Breast Cancer: From the Personal to the Political | url = http://books.google.ca/books?id=C9XHrABMdwsC
| title=The Journey Beyond Breast Cancer: From the Personal to the Political | url = https://books.google.com/books?id=C9XHrABMdwsC
| publisher= ]
| publisher=]
| location=Rochester, Vt
| location=Rochester, VT
| year=1994 | year=1994
| oclc = 26217697 | oclc = 26217697
| isbn=0-89281-448-9 }} | isbn=978-0-89281-448-0
}}
* {{cite news * {{cite magazine
| last=Stukin | last=Stukin
| first=Stacie | first=Stacie
| title=Pink Ribbon Promises | title=Pink Ribbon Promises
| magazine=]
| journal=]
| date=8 October 2006 | date=8 October 2006
| issn = 0040-781X | issn = 0040-781X
| url=http://www.time.com/time/magazine/article/0,9171,1543947-1,00.html }} | url=http://content.time.com/time/magazine/article/0,9171,1543947,00.html
| archive-url=https://web.archive.org/web/20070930115411/http://www.time.com/time/magazine/article/0,9171,1543947-1,00.html
| url-status=live
| archive-date=30 September 2007
}}
* {{cite book * {{cite book
| author=Sulik, Gayle | last=Sulik
| first=Gayle
| title=Pink Ribbon Blues: How Breast Cancer Culture Undermines Women's Health | url = http://books.google.ca/books?id=7WG5VzIzOAwC
| title=Pink Ribbon Blues: How Breast Cancer Culture Undermines Women's Health
| url = https://books.google.com/books?id=7WG5VzIzOAwC
| publisher= ] | publisher= ]
| location=New York | location=New York
| year=2010 | year=2010
| oclc = 535493589 | oclc = 535493589
| isbn=0-19-974045-3}} | isbn=978-0-19-974045-1
}}
* {{cite news * {{cite news
| author=Welch, H. Gilbert | last=Welch
| first=H. Gilbert
| title= The Risk of Being Too Aware | title= The Risk of Being Too Aware
| journal=] | journal=]
| date=20 October 2010 | date=20 October 2010
| issn = 0458-3035 | issn = 0458-3035
| url=http://www.latimes.com/news/opinion/commentary/la-oe-welch-mammograms-20101020,0,2961910.story }} | url=https://www.latimes.com/archives/la-xpm-2010-oct-20-la-oe-welch-mammograms-20101020-story.html
}}
* {{cite news | last = Zuger | first = Abigail | date = 2010-10-25 | work = ] | url = http://www.nytimes.com/2010/10/26/health/26zuger.html?_r=0 | title = Breast Cancer Tales: The Inspirational vs. the Actual }}
* {{cite web
| author=World Health Organization|author-link=World Health Organization| year= 2004 | work = The world health report 2004 -changing history | title = Annex Table 2: Deaths by cause, sex and mortality stratum in WHO regions, estimates for 2002 | url =https://www.who.int/entity/whr/2004/annex/topic/en/annex_2_en.pdf | access-date = 2008-11-01}}
* {{cite news
| last = Zuger
| first = Abigail
| title = Breast Cancer Tales: The Inspirational vs. the Actual
| date = 25 October 2010
| newspaper = The New York Times
| url = https://www.nytimes.com/2010/10/26/health/26zuger.html?_r=0
}}


==Further reading== ==Further reading==
{{Commons category}} {{Commons category|Breast cancer awareness}}
* {{cite book * {{cite book
|author=Aronowitz, Robert A. |last=Aronowitz |first=Robert A.
|title=Unnatural history: breast cancer and American society |title=Unnatural History: Breast Cancer and American Society
|publisher= ] | url = http://books.google.ca/books?id=VBiQU8Jk-9wC |publisher= ] | url = https://books.google.com/books?id=VBiQU8Jk-9wC
|location=Cambridge, UK |location=Cambridge, UK
|year=2007 |year=2007
|isbn=0-521-82249-1 |isbn=978-0-521-82249-7
|oclc= }} }}
* {{cite book * {{cite book
|author=Kasper, Anne S.; Ferguson, Susan J. |last1=Kasper |first1=Anne S. |last2=Ferguson |first2=Susan J.|author2-link=Susan J. Ferguson
|title=Breast cancer: society shapes an epidemic |title=Breast Cancer: Society Shapes an Epidemic
|publisher= ] | url = http://books.google.ca/books?id=I9sO_TiIh4UC |publisher= ] | url = https://books.google.com/books?id=I9sO_TiIh4UC
|location=Basingstoke |location=Basingstoke
|year=2002 |year=2002
|isbn=978-0-312-29451-9
|pages=
}}
|isbn=0-312-29451-4
|oclc= }}
* {{cite book * {{cite book
|author=Klawiter, Maren |last=Klawiter |first=Maren
|title=The biopolitics of breast cancer: changing cultures of disease and activism | url = http://books.google.ca/books?id=tIC3UA58B7UC |title=The Biopolitics of Breast Cancer: Changing Cultures of Disease and Activism | url = https://books.google.com/books?id=tIC3UA58B7UC
|publisher= ] |publisher= ]
|location=Minneapolis |location=Minneapolis
|year=2008 |year=2008
|isbn=978-0-8166-5108-5
|pages=
}}
|isbn=0-8166-5108-6
|oclc= }}
* {{cite book * {{cite book
|author=Leopold, Ellen |last=Leopold |first=Ellen
|title=A Darker Ribbon: A Twentieth-Century Story of Breast Cancer, Women, and Their Doctors |title=A Darker Ribbon: A Twentieth-Century Story of Breast Cancer, Women, and Their Doctors
|publisher= ] | url = http://books.google.ca/books?id=QUef2RsscSMC |publisher= ] | url = https://books.google.com/books?id=QUef2RsscSMC
|location=
|year=2000 |year=2000
|isbn=978-0-8070-6513-6
|pages=
}}
|isbn=0-8070-6513-7
|oclc= }}
* {{cite book * {{cite book
|author=Lerner, Barron H.; Barron H., Md Lerner |last=Lerner |first=Barron H.
|title=The breast cancer wars: hope, fear, and the pursuit of a cure in twentieth-century America |title=The Breast Cancer Wars: Hope, Fear, and the Pursuit of a Cure in Twentieth-century America
|publisher= ] | url = http://books.google.ca/books?id=Ut0o3gwHRekC |publisher= ] | url = https://books.google.com/books?id=Ut0o3gwHRekC
|location=Oxford |location=Oxford
|year=2001 |year=2001
|isbn=978-0-19-516106-9
|pages=
}}
|isbn=0-19-516106-8
* {{cite news
|oclc= }}
| first = Carpenter
| last = Mackenzie
| date = 1 October 2006
| url = http://www.post-gazette.com/stories/sectionfront/life/just-about-everything-turns-pink-for-cancer-in-october-452768/
| title = Just about Everything Turns Pink for Cancer in October
| work = ]
}}


{{Breast cancer}} {{Breast cancer}}


]
{{Use dmy dates|date=August 2011}}

<!-- CATEGORIES -->
]
]
]
]
] ]

Latest revision as of 23:16, 27 September 2024

Effort to raise awareness and reduce the stigma of breast cancer Not to be confused with Breast awareness.

Breast cancer awareness ribbon in Louisville, Kentucky

Breast cancer awareness is an effort to raise awareness and reduce the stigma of breast cancer through education about screening, symptoms, and treatment. Supporters hope that greater knowledge will lead to earlier detection of breast cancer, which is associated with higher long-term survival rates, and that money raised for breast cancer will produce a reliable, permanent cure.

Breast cancer advocacy and awareness efforts are a type of health advocacy. Breast cancer advocates raise funds and lobby for better care, more knowledge, and more patient empowerment. They may conduct educational campaigns or provide free or low-cost services. Breast cancer culture, sometimes called pink ribbon culture, is the cultural outgrowth of breast cancer advocacy, the social movement that supports it, and the larger women's health movement.

The pink ribbon is the most prominent symbol of breast cancer awareness, and in many countries, the month of October is National Breast Cancer Awareness Month. Some national breast cancer organizations receive substantial financial support from corporate sponsorships.

Breast cancer awareness campaigns have been criticized for minimizing the risks of screening programs, conflicts of interest, and a narrow focus of research funding on screening and existing treatments at the expense of prevention and new treatments.

Marketing approaches

The goal of breast cancer awareness campaigns is to raise the public's brand awareness for breast cancer, its detection, its treatment, and the need for a reliable, permanent cure. Increased awareness has increased the number of women receiving mammograms, the number of breast cancers detected, and the number of women receiving breast biopsies. Overall, as a result of awareness, breast cancers are being detected at an earlier, more treatable stage. Awareness efforts have successfully utilized marketing approaches to reduce the stigma associated with the disease.

Generally speaking, breast cancer awareness campaigns have been highly effective in getting attention for the disease. Breast cancer receives significantly more media coverage than other prevalent cancers, such as prostate cancer.

Breast cancer as a brand

A pink ribbon, an international symbol of breast cancer awareness.

Breast cancer advocacy uses the pink ribbon and the color pink as a concept brand to raise money and increase screening. The breast cancer brand is strong: people who support the "pink brand" are members of the socially aware niche market, who are in favor of improved lives for women, believe in positive thinking, trust biomedical science to be able to solve any problem if given enough money, and prefer curative treatments to prevention.

The brand ties together fear of cancer, hope for early identification and successful treatment, and the moral goodness of women with breast cancer and anyone who visibly identifies themselves with breast cancer patients. This brand permits and even encourages people to substitute conscientious consumption and individual symbolic actions, like buying or wearing a pink ribbon, for concrete, practical results, such as collective political action aimed at discovering non-genetic causes of breast cancer.

The establishment of the brand and the entrenchment of the breast cancer movement has been uniquely successful because no countermovement opposes the breast cancer movement or believes that breast cancer is desirable.

Pink ribbon

Main article: Pink ribbon

A pink ribbon is a symbol of breast cancer awareness. It may be worn to honor those who have been diagnosed with breast cancer, or to identify products that a manufacturer would like to sell to consumers that are interested in breast cancer. Pink ribbons are sometimes sold as fundraisers, much like poppies on Remembrance Day.

The pink ribbon is associated with individual generosity, faith in scientific progress, and an optimistic "can-do" attitude. It encourages individuals to focus on the emotionally appealing ultimate vision of a cure for breast cancer, rather than the reality that there is neither any certain cure for breast cancer nor any guarantee there will ever be such a cure. The practice of blindly wearing or displaying a pink ribbon without making other, more concrete efforts to prevent or cure breast cancer has been described as a kind of slacktivism due to its lack of real effects, and has been compared to equally simple yet ineffective "awareness" practices like the drive for women to post the colors of their bras on Facebook. Critics say that the feel-good nature of pink ribbons and "pink consumption" distracts society from the lack of progress in curing breast cancer. It is also criticized for reinforcing gender stereotypes and objectifying women and their breasts.

Events

Large events, such as walkathons, promote breast cancer awareness.
Main article: Breast Cancer Awareness Month

Each year, the month of October is recognized as Breast Cancer Awareness Month by many governments, the media, and cancer survivors. The month-long campaign has been called Pinktober because of the increased production of pink goods for sale, and National Breast Cancer Industry Month by critics like Breast Cancer Action. BCAM was begun in 1985 by the American Cancer Society and pharmaceutical company AstraZeneca. The organization that runs the official BCAM aims to promote mammography and other forms of early detection as the most effective means of fighting breast cancer.

Typical BCAM events include fundraising-based foot races, walk-a-thons, and bicycle rides. Participants solicit donations to a breast cancer-related charity in return for running, walking, or riding in the event. Through mass-participation events, breast cancer survivors form a single, united group that speaks and acts consistently and shares a coherent set of beliefs. They also reinforce the cultural connection between each individual's physical fitness and moral fitness. Events organized by Avon or Komen are known to allocate around 25%-33% of donations to the funds needed to organize the event and advertise it.

A breast cancer awareness program is presented in India to Muslim women in 2013.

Various landmarks are illuminated in pink lights as a visible reminder of breast cancer, and public events, such as American football games, may use pink equipment or supplies. In 2010, all King Features Syndicate comic strips on one Sunday were printed in shades of red and pink, with a pink ribbon logo appearing prominently in one panel.

Private companies may arrange a "pink day", in which employees wear pink clothes in support of breast cancer patients, or pay for the privilege of a relaxed dress code, such as Lee National Denim Day. Some events are directed at people in specific communities, such as the Global Pink Hijab Day, which was started in America to encourage appropriate medical care and reduce the stigma of breast cancer among Muslim women, and Male Breast Cancer Awareness Week, which some organizations highlight during the third week of October. Most events are well-received, but some, like the unauthorized painting of the Pink Bridge in Huntington, West Virginia, are controversial.

Many cancer survivors find that BCAM is an emotionally difficult time, as it reminds them of a distressing time and because the cheerful marketing images do not match their experiences.

Companies and consumers

The basket contains an assortment of pink ribbon-branded promotional merchandise, including awareness bracelets, ink pens, candy, and emery boards.

Thousands of breast cancer-themed products are developed and sold each year. Some of these items are everyday products that have been repackaged or repositioned to take advantage of cause-related marketing, such as teddy bears, clothing, jewelry, candles, and coffee mugs. These blended value objects offer consumers an opportunity to simultaneously buy an object and make a donation to a breast cancer organization. Some of these products are produced and/or sold by breast cancer survivors or charities for fundraising purposes, while others are for profits in addition to fundraising. Manufacturers also produce products with pink labels or pink ribbon logos to donate a sum of money to support the cause. The donation is typically capped so that it is reached after a fixed level of sales, although in some cases the company is providing only free advertising for a selected charity. Although advertising costs are rarely disclosed, some companies have been found to spend far more money advertising "pink products" and tie-ins than they donate to charitable organizations supporting research or patients. For example, in 2005, 3M spent US$500,000 advertising post-it notes printed with a pink ribbon logo. Sales were nearly double what the company expected, but the campaign resulted in a $300,000 donation.

Advertisers and retail consultants have said that because of consumer cynicism, a company can benefit from marketing its support for a cause such as breast cancer awareness only when the company treats that support as "a commitment and not a marketing opportunity". Andrew Benett, an executive at Euro RSCG said that because consumers "have become more mindful, more thoughtful, about how they consume, where they consume, why they consume", companies cannot succeed by "just slapping a pink ribbon on a product and people will buy more". Pink products have also been condemned as promoting consumerism, materialism, and environmental degradation. Critics are also concerned that the ubiquity of pink products may mislead people into thinking that significant progress has been made, and that small, individual actions, like buying a breast cancer-themed product, are sufficient. Responding to criticism, Komen CEO Nancy G. Brinker said that corporate promotions enabled the organization to reach new audiences and that "America is built on consumerism. To say we shouldn't use it to solve the social ills that confront us doesn't make sense to me".

The first breast cancer awareness stamp in the U.S., featuring a pink ribbon, was issued in 1996. As it did not sell well, a semi-postal stamp without a pink ribbon, the breast cancer research stamp, was designed in 1998. Products like these emphasize the relationship between being a consumer and supporting women with breast cancer. In Canada, the Royal Canadian Mint produced 30 million 25-cent coins with pink ribbons during 2006 for normal circulation. Designed by the mint's director of engraving, Cosme Saffioti (reverse), and Susanna Blunt (obverse), this colored coin is the second in history to be put into regular circulation.

Pink Ribbon chocolates

Business marketing campaigns, particularly sales promotions for products that increase pollution or have been linked to the development of breast cancer, such as alcohol, high-fat foods, some pesticides, or the parabens and phthalates used by most cosmetic companies, have been condemned as pinkwashing (a portmanteau of pink ribbon and whitewash). Such promotions generally result in a token donation to a breast cancer-related charity by taking advantage of the consumers' fear of cancer and grief for people who have died to drive sales. Critics say that these promotions, which net more than US$30 million each year just for fundraising powerhouse Susan G. Komen for the Cure, do little more than support the marketing machines that produce them. Komen says that corporate sponsorships are necessary to pay for the organization's efforts: in the 2010 fiscal year it spent $175 million on public health education and awareness campaigns, $75 million on medical research and about $67 million on treatment and screenings for patients.

Two significant campaigns against pink consumption are the National Breast Cancer Coalition's "Not Just Ribbons" campaign, and Breast Cancer Action's "Think Before You Pink" campaign. NBCC's "Not Just Ribbons" campaign sought to focus awareness efforts onto substantive issues such as genetic discrimination, access to cancer treatment, patient rights, and environmental breast cancer research. "Think Before You Pink" encouraged consumers to ask questions about pink products (e.g., to find out how much of a donation was being made).

Advertisements

This trolley advertisement promotes cosmetics company Avon Products, Inc. and breast cancer awareness. Because of the pink ribbon brand's strength, the advertisement is easily recognized as a promotion for breast cancer awareness, even among people who cannot read the Japanese text.

Many corporate and charitable organizations run advertisements related to breast cancer, especially during National Breast Cancer Awareness Month, in the hope of increasing sales by aligning themselves with a positive, helpful message. In addition to selling pink products, corporate advertisements may promote the company's progressive policies, or may provide free advertising for a chosen charity. Medical institutions may run advertisements for mammogram or other breast-related services. Non-profit organizations often benefit from public service announcements, which are free advertisements provided by newspapers, radio and television stations, and other media. Some marketing blurs the line between advertisements and events, such as flash mobs as a form of guerrilla marketing. The typical participant in the breast cancer movement, and therefore the advertisers' target audience, is a white, middle-aged, middle-class, well-educated woman.

Some corporate sponsors are criticized for having a conflict of interest. For example, some of the prominent sponsors of these advertisements include businesses that sell the expensive equipment needed to perform screening mammography; an increase in the number of women seeking mammograms means an increase in their sales, which has led critics to say that their sponsorship is not a voluntary act of charity, but an effort to increase sales. The regulated drug and medical device industry uses the color pink, positive images, and other themes of the pink ribbon culture in direct-to-consumer advertising to associate their breast cancer products with the fear, hope, and wholesome goodness of the breast cancer movement. This is particularly evident in advertisements designed to sell screening mammograms.

Social role of the woman with breast cancer

A woman being treated with docetaxel chemotherapy for breast cancer. She keeps ice packs on her hands and feet to reduce temporary damage to her fingernails and toenails.

The marketing of breast cancer awareness allows people to incorporate support for awareness into their personal identity or lifestyle. Socially aware, pro-woman individuals, businesses, politicians, and organizations use pink ribbons and other trappings of breast cancer awareness to signal their support for women, health, and mainstream medicine.

The she-ro

The term she-ro, derived from hero, is used in discussions of breast cancer to refer to women who have been diagnosed with breast cancer, and sometimes to those who have survived breast cancer. The term describes an "idealized" patient who combines assertiveness, optimism, femininity and sexuality, despite the effects of treatment, and as a "paragon uses a diagnosis of breast cancer as a catalyst for a personal transformation".

Sociologist Gayle Sulik analyzed the she-ro's social role and ascribes it qualities that include being an educated medical consumer with a brave, pleasant and optimistic public appearance and demeanor, who aggressively fights breast cancer through compliance with screening guidelines and "disciplined practice of 'breast health'". In America the she-ro is diagnosed early due to adherence to early screening recommendations, and, by definition, she survives her diagnosis and treatment. The role emphasizes the femininity and female gender role of the she-ro, offsetting the masculine characteristics of assertiveness, selfishness and "fighting" cancer by cultivating a feminine appearance and concern for others. During and after treatment, the she-ro regains her femininity by using breast reconstruction, prosthetic devices, wigs, cosmetics, and clothing to present an aesthetically appealing, upper-class, heterosexual feminine appearance and by maintaining relationships in which she can nurture other people. Following the proper feeling rules of the breast cancer culture is encouraged, including remaining optimistic of a full cure, rationalizing the selfishness of treatment as a temporary measure, and feeling guilty that it forces her to put her needs momentarily above the needs of others or due to her perceived inadequacy in caring for her family or other women with cancer. Also included in the role is a form of the have-it-all superwoman, cultivating a normal appearance and activity level and minimizing the disruption that breast cancer causes to people around her.

Consequences

The effort of maintaining the role of a she-ro can be stressful. The role encourages women with breast cancer to care for others rather than themselves. Some of them find this comforting, but it may lead to them feeling reluctant or unable to ask for the help they need or want, and this can lead to bitterness that their friends and family did not offer these services unbidden. The success of their efforts to look and act normally may paradoxically increase their dissatisfaction, as their apparent ability to handle it all discourages people from offering help.

The breast cancer culture celebrates women who display the attitude deemed correct, which implies that their continued survival is due to this positive attitude and fighting spirit. While cheerfulness, hope, and good social support can be advantageous to health outcomes, it cannot determine survival rates. Women who reject the she-ro model may find themselves socially isolated by the breast cancer support groups that are nominally supposed to help them. Support from "the sisterhood" favors the "passionately pink", and tends to overlook women whose response to being diagnosed with breast cancer is incompatible with the pink ribbon culture, because they feel angry, unhappy, or afraid.

The breast cancer culture is ill-equipped to deal with women who are dying or who have died, and their experiences may not be memorialized, validated or represented as part of the movement, instead being ignored or shunned as failures and as hope-destroying examples of reality. They may feel like treatment failure is a "dirty little secret" that others want to make invisible. Similarly, the culture is also ill-equipped to deal with the news that a previously hyped treatment or screening procedure has been determined to be ineffective, with women advocating for the acceptance and promotion of inexpedient activities and inefficient or even sometimes harmful drugs.

Breast cancer culture

Breast cancer culture, or pink ribbon culture, is the set of activities, attitudes, and values that surround and shape breast cancer in public. The dominant values are selflessness, cheerfulness, unity, and optimism. It is pro-doctor, pro-medicine, and pro-mammogram. Health care professionals are sources of information, but the rightness of their advice is not to be seriously questioned by women with breast cancer. Patients are not encouraged to ask where research money is going or if the research industry is making progress in finding the "cure". The emphasis on cheerfulness allows society to blame women for developing breast cancer and limits their responses to certain culturally determined scripts. The requirement of cheerful optimism arose from the then-popular theory that cancer had a psychosomatic origin and that people who were diagnosed with cancer had a "cancer personality" that was depressed, repressed, and self-loathing. Psychotherapy was therefore considered an adjunct treatment used to produce a cheerful, self-affirming identity. This theory was predominant among psychiatrists through the 1970s, but has since been discredited. In a process called benefit finding, the she-ro uses the emotional trauma of being diagnosed with breast cancer and the suffering of extended treatment to transform herself into a stronger, happier and more sensitive person who is grateful for the opportunity to become a better person. In particular, she sees breast cancer as an opportunity to give herself permission for necessary personal growth that she felt she was prohibited from or unable to make before. Breast cancer thereby becomes a rite of passage rather than a disease, with pink ribbon culture honoring the suffering of its she-roes by selecting them based on the amount of misery they have experienced, and leading women whose treatment is less painful or debilitating to feel excluded and devalued. The suffering, particularly the extended suffering of months of chemotherapy and radiation treatment, forms a metaphorical type of ordeal or rite of passage that initiates women into the inner circle of breast cancer culture. Barbara Ehrenreich describes it this way:

Understood as a rite of passage, breast cancer resembles the initiation rites so exhaustively studied by Mircea Eliade: First there is the selection of the initiates—by age in the tribal situation, by mammogram or palpation here. Then come the requisite ordeals—scarification or circumcision within traditional cultures, surgery and chemotherapy for the cancer patient. Finally, the initiate emerges into a new and higher status—an adult and a warrior—or in the case of breast cancer, a "survivor".

Mainstream pink ribbon culture has aspects that are trivializing, silencing, and infantilizing. Women with breast cancer are surrounded by childish kitsch such as pink teddy bears and crayons, but there is no equivalent gift of toy cars for men diagnosed with prostate cancer. Women who choose not to conform to the culture may feel excluded and isolated; those who cannot conform to the prescribed triumphant script report feeling unable to share their stories honestly. Anger, negativity and fatalism transgress the feeling rules, and women with breast cancer who express anger or negativity are corrected by other women with breast cancer and members of the breast cancer support organizations. Appearing unattractive—such as going out in public with a bare, bald head if treatment causes temporary hair loss—transgresses the approved, upper-class style of pink femininity and provokes shaming comments from strangers. Programs such as Reach to Recovery and Look Good, Feel Better inform breast cancer patients of this cultural standard and help them conform to it. This standard is not universally adhered to in every detail. Ehrenreich says that "he question of wigs versus baldness ... defines one of the few real disagreements in breast-cancer culture." Some women have avant garde aesthetic tastes: "One decorates her scalp with temporary tattoos of peace signs, panthers, and frogs; another expresses herself with a shocking purple wig; a third reports that unadorned baldness makes her feel 'sensual, powerful, able to recreate myself with every new day'". Regardless of whether the transformation is towards a radical, natural or cosmetically enhanced appearance, treatment is always "a makeover opportunity".

Since the beginning of the 21st century, breast cancer culture has become more sexualized, and many awareness campaigns now reflect the old advertising truism that sex sells. The "booby campaigns", such as "Save the Tatas" and the "I ♥ Boobies" gel bracelets, rely on a cultural obsession with breasts and a market that is already highly aware of breast cancer. This message trivializes women and reflects a belief that breast cancer is important because cancer and its treatment makes women feel less sexually desirable and interferes with men's sexual access to women's breasts, instead of because cancer and its treatment kill and disable women. These sexualized campaigns tend to attract a younger audience than traditional campaigns.

At the same time, breast cancer culture tends to overlook men with breast cancer and women who do not fit the white, middle-class archetype. African-Americans involved with breast cancer organizations often feel like their role is to be the token minority.

The primary purposes or goals of the breast cancer culture itself are to maintain breast cancer's dominance as the preëminent women's health issue, to promote the appearance that society is "doing something" effective about breast cancer, and to sustain and expand the social, political, and financial power of breast cancer activists.

The breast cancer culture tells women with breast cancer that their participation in fundraising, social support of other women with breast cancer, and appearance at public events are critical activities that promote their own emotional recovery. Because of this message, some women begin to believe that refusing to raise money for breast cancer organizations or to become mentors for newly diagnosed women with breast cancer is an unhealthy response to breast cancer.

Feminism and the breast cancer wars

The breast cancer wars were a series of conflicts between advocates and others about the causes, treatments, and societal responses to breast cancer. Women in the late 1980s and 1990s followed the successful approach used by ACT-UP and other AIDS awareness groups, of staging media-friendly protests to increase political pressure. Prominent women who made the "wrong" choice were publicly excoriated, as when Nancy Reagan chose mastectomy over lumpectomy followed by six weeks of radiation therapy. The abortion–breast cancer hypothesis was formulated when an early study showed a connection between voluntary abortions and the development of breast cancer in premenopausal women, which pitted breast cancer advocates against abortion rights advocates.

Advocates for women's issues have said that breast cancer is special because of its status as a largely female disease, society's response to it is an ongoing indication of the status of women and the existence of sexism. Breast cancer activist Virginia Soffa wrote that "s long as it is not a national priority, the breast cancer epidemic will remain a metaphor for how society treats women". Barbara Ehrenreich writes that, before the feminist movement "medicine was a solid patriarchy", and women with breast cancer were often treated as passive, dependent objects, incapable of making appropriate choices, whose role was to accept whatever treatment was decreed by the physicians and surgeons, who held all of the power. Because of sexism in education, female surgeons were far outnumbered by their male counterparts, and until the 1990s, when Susan Love of the University of California, Los Angeles Breast Center published Dr. Susan Love's Breast Book, the physicians who provided breast cancer treatments were generally men. Love said that some male physicians tended to impose their own values on women, such as recommending mastectomy to older women because, being past the age of child bearing and breastfeeding, they no longer "needed" their breasts. The women's health movement promoted mutual aid, self-help, networking, and an active, informed role in the patient's health care. Since the end of the breast cancer wars, feminists have again objected to the breast cancer culture's treatment of women with breast cancer as little girls who need to be obedient to authority figures, cooperative, pleasant and pretty.

Achievements of the breast cancer movement

Social progress

Breast cancer has been known to educated women and caregivers throughout history, but modesty and horror at the consequences of a largely untreatable disease made it a taboo subject. The breast cancer movement, which developed in the 1980s and 1990s out of 20th century feminist movements and the women's health movement, has mostly removed those taboos through its modern advocacy and awareness campaigns.

Educated, empowered patients

At the beginning and middle of the 20th century, breast cancer was usually discussed in hushed tones, as if it were shameful. As an example, The New York Times refused to publish an advertisement for a breast cancer support group in the early 1950s, stating that it would not print either the word breast or the word cancer. Later, however, several celebrities publicly disclosed their own health challenges, and the resulting publicity reduced the stigma. One of the first was Shirley Temple Black, the former child star, who announced her diagnosis in 1972. In October 1974, Betty Ford, the wife of the then-President of the United States, openly discussed her breast cancer diagnosis and mastectomy. Two weeks later, the wife of the then-Vice President also had a mastectomy for breast cancer. The next year, journalist Rose Kushner published her book, Breast Cancer: A Personal History and Investigative Report, which she had written while recovering from a modified radical mastectomy. More recently, Angelina Jolie has also come forward publicly regarding her experience surrounding her diagnosis and treatment, which managed to raise public awareness of the issue significantly. In one study, when a survey of women was taken following Jolie's announcement, awareness rose by 4% among those women surveyed. The media reported these women's health and their treatment choices, and even invited some to appear on talk shows to discuss breast cancer frankly.

The breast cancer movement has resulted in widespread acceptance of second opinions, the development of less invasive surgical procedures, the spread of support groups, and other advances in patient care. The movement successfully separated diagnostic biopsy from mastectomy surgery; before about 1980, it was common to perform the biopsy and, if a quick review of tissues indicated a probable need, a mastectomy in the same surgery. The one-step surgery prevented women from seeking different opinions about their treatment, and sent them into the surgery without knowing whether their breasts would be removed that day. In response to women's concerns over lymphedema after routine removal of lymph nodes during mastectomy, the more limited approach of sentinel node biopsy was developed. Advocacy efforts also led to the formal recommendation against the routine use of the Halsted radical mastectomy in favor of simple mastectomies and lumpectomies.

The breast cancer movement has supported practical, educational, emotional, and financial care for women with breast cancer. Support groups, individual counseling opportunities, and other resources are made available to patients.

Educational interventions using written material and brief one-to-one interaction about breast checking behaviour, breast cancer symptoms and age-related risk have the potential to increase breast cancer awareness in older women, over a sustained period of time.

Increased resources for treatment and research

Supporting breast cancer detection and treatment was seen as a distinctively pro-woman stance popular among public official. This has resulted in better access to care. For example, in much of the United States, low-income women with breast cancer may qualify for taxpayer-funded health care benefits, such as screening mammography, biopsies, or treatment, while women with the same income, but another form of cancer or a medical condition other than cancer, do not.

Breast cancer advocates have successfully increased the amount of public money being spent on cancer research and shifted the research focus away from other diseases and towards breast cancer. Breast cancer advocates also raise millions of dollars for research into cures each year, although most of the funds they raise is spent on screening programs, education and treatment. Most breast cancer research is funded by government agencies.

The high level of awareness and organized political lobbying has resulted in a disproportionate level of funding and resources given to breast cancer research and care. Favoring breast cancer with disproportionate research may have the unintended consequence of costing lives elsewhere. In 2001 UK MP Ian Gibson said, "The treatment has been skewed by the lobbying, there is no doubt about that. Breast cancer sufferers get better treatment in terms of bed spaces, facilities and doctors and nurses".

Risks of over-awareness

Causes of death among women: Breast cancer is the cause of death of 2% of women.
Source: WHO (2004)

  Deaths from breast cancer (2%)  Deaths from heart disease or stroke (32%)  Deaths from other cancers (10%)  Other (56%)

Awareness has also led to increased anxiety for women. Early detection efforts result in overdiagnosis of precancerous and cancerous tumors that would never risk the woman's life (about one-third of breast cancers diagnosed through screening programs), and result in her being subjected to invasive and sometimes dangerous radiological and surgical procedures.

In recent years, the definition of breast cancer has expanded to include non-invasive, non-cancerous conditions like lobular carcinoma in situ (LCIS) and pre-cancerous or "stage 0" conditions like ductal carcinoma in situ (DCIS). Despite the now-regretted decision to use the word carcinoma in these relatively common conditions (almost a quarter of "breast cancer" diagnoses in the US), they are not life-threatening cancers. Women with these conditions are promoted as breast cancer survivors due to the fear they experienced before they became educated about their condition, rather than in respect of any real threat to their lives. This effectively increases the market size for breast cancer organizations, medical establishments, pharmaceutical manufacturers, and the makers of mammography equipment.

Women fear dying from breast cancer more than dying from heart disease, even though, as of 2006, eleven times as many women died from heart disease and stroke as from breast cancer. According to cardiologist Lisa Rosenbaum, this may be because women "view heart disease as the consequence of having done something bad, whereas to get breast cancer is to have something bad happen to you".

An emphasis on educating women about lifestyle changes that may have a small impact on preventing breast cancer often makes women feel guilty if they do develop breast cancer. Some women decide that their own cancer resulted from poor diet, lack of exercise, or other modifiable lifestyle factor, even though most cases of breast cancer are due to non-controllable factors, like genetics or naturally occurring background radiation. Adopting such a belief may increase their sense of being in control of their fate. Increased awareness inadvertently increases victim blaming. Women who resist screening mammography or breast self-exams are subjected to social pressure, scare tactics, guilt, and threats from some physicians to terminate the relationship with the patient. Similarly, the emphasis on early detection results in many women wrongly blaming themselves if their cancer is not detected at an early stage.

The promotion of research to make screening programs find ever more cancers is also criticized. One-third of diagnosed breast cancers might recede on their own. In addition to efficiently finding most deadly cancers, screening programs also find most non-life-threatening, asymptomatic breast cancers and pre-cancers, and miss some fast growing, aggressive, dangerous cancers. According to H. Gilbert Welch of the Dartmouth Institute for Health Policy and Clinical Practice, "I'm certainly not asking anyone to stop getting mammograms. I am asking my profession to tell women the truth about overdiagnosis". Welch said that research on screening mammography has taken the "brain-dead approach that says the best test is the one that finds the most cancers" rather than the one that finds dangerous cancers.

Clinicians have responded that they are unwilling to consider the possibility of leaving potential deadly cancers alone because it is "far-riskier" than the alternative. Eric Winer, director of the breast cancer program at Dana-Farber Cancer Institute in Boston, says, "I don't know anyone who offers women the option of doing nothing". Further complicating the issue of early diagnosis is the fact that it is currently impossible to distinguish malicious cancers from benign ones. Otis Brawley, a top official for the American Cancer Society, says that "even if we overdiagnose 1 in 5, we have numerous studies showing that by treating all these women, we save a bunch of lives". For instance, a 2011 Cochrane review showed a sample of mammogram screening programs resulted in a 15% reduction in mortality rate despite over-diagnosis, indicating that mammography programs save lives regardless of over-diagnosis.

Conflicts of interest in organizations

Some critics say that breast cancer awareness has transformed the disease into a market-driven industry of survivorship and corporate sales pitches. Corporate marketing machines promote early detection of breast cancer, while also opposing public health efforts, such as stricter environmental legislation, that might decrease the incidence rate of breast cancer. These critics believe that some of the breast cancer organizations, particularly the highly visible Susan G. Komen for the Cure, have become captive companies that support and provide social capital to the breast cancer industry, including pharmaceutical companies, mammography equipment manufacturers, and pollution-causing industries, as well as large corporations, creating or exacerbating other problems.

For example, Ford Motor Company ran a "Warriors in Pink" promotion on their Ford Mustang sports car, which critics say was intended to sell cars and counter the bad publicity the company received by reducing its workforce by tens of thousands of people, causing many of them to lose their health insurance, rather than to prevent or cure breast cancer. A Ford spokesperson acknowledged that the objective of the promotion was to "do good works throughout the community and derive some marketing exposure at the same time", but said that over the promotion's 15 years the company had donated $100 million and that the company continued the program during the automotive industry crisis of 2008–2010 because "It's part of our DNA now." Ford believes that the recipient of the funds, Susan G. Komen for the Cure, benefited because Ford helped it reach "people who might not have thought of this organization before or may be supporting other organizations".

However, the primary sponsors are part of the breast cancer industry, particularly cancer drug makers like AstraZeneca, Bristol-Myers Squibb, and Novartis. Because the national breast cancer organizations are dependent on corporate sponsorships for survival, this situation may represent a conflict of interest that prevents these organizations from representing the needs of current and future people with breast cancer when those needs conflict with the profit-making motives of the corporate sponsors.

The structure of the breast cancer movement may allow large organizations to claim to be the voice of women with breast cancer, while simultaneously ignoring their desires.

Some breast cancer organizations, such as Breast Cancer Action, refuse to accept funds from medical or other companies they disapprove of.

Environmental breast cancer movement

Most of the money raised by advocates is spent on increasing awareness, cancer screening, and existing treatments. Only a small fraction of the funds is spent on research, and less than 7% of the total research funding provided by breast cancer organizations goes to prevention. Instead, most of the charities fund research into detection and treatment. Advocates like Breast Cancer Action and women's health issues scholar Samantha King, whose book inspired the 2011 documentary Pink Ribbons, Inc., are unhappy that relatively little money or attention is devoted to identifying the non-genetic causes of breast cancer or to preventing breast cancer from occurring. The mainstream breast cancer culture has been criticized for focusing on detecting and curing existing breast cancer cases, rather than on preventing future cases.

As a result, screening mammography is promoted by the breast cancer culture as the sole possible approach to public health for breast cancer. Alternatives, such as pollution prevention, are largely ignored.

As the majority of women with breast cancer have no risk factors other than sex and age, the environmental breast cancer movement suspects pollution as a significant cause, possibly from pesticides, plastics, and industrial runoff in ground water. Large organizations, such as Susan G. Komen for the Cure and the American Cancer Society, are not part of the environmental breast cancer movement. These large organizations benefit the most from corporate sponsorships that critics deride as pinkwashing, e.g., polluting industries trying to buy public goodwill by publishing advertisements emblazoned with pink ribbons, rather than stopping their pollution under the precautionary principle.

The non-genetic factors with consistent evidence increasing breast cancer risk include "ionizing radiation, combination estrogen–progestin hormone therapy, and greater postmenopausal weight. ... for many other factors, the evidence from human studies is more limited, contradictory, or absent" and called for additional research. Conducting research into whether a chemical causes cancer is difficult, because "suspect chemicals cannot ethically be given to people to see if they cause cancer. People exposed in the past can be studied, but information about the dose and timing may be sketchy. Animal studies can provide useful information, but do not always apply to humans. And people are often exposed to mixtures of chemicals that may interact in complex ways, with effects that may also vary depending on an individual's genetic makeup".

Samantha King says that prevention research is minimized by the breast cancer industry because there is no way to make money off of cases of breast cancer that do not happen, whereas a mammography imaging system that finds more possible cancers, or a "magic bullet" that kills confirmed cancers, would be highly profitable.

Breast Cancer Action

Main article: Breast Cancer Action

Breast Cancer Action is an American grassroots education and advocacy organization that promotes breast cancer awareness and public health issues relating to breast cancer, and advocates for system-wide change based on prevention. Breast Cancer Action is also known for its Think Before You Pink campaign, launched in 2002, which encourages consumers to ask critical questions before buying pink ribbon products.

Dissent through art

While the pink ribbon culture is dominant, there are alternatives. The environmental breast cancer movement is one type of dissent. Another is the rejection of compliant optimism, aesthetic normalization, and social pleasingness that the pink ribbon culture promotes.

In 1998, the Art.Rage.Us art collective published a book that collected some of the art work from their traveling collection. This included art that was shocking, painful and realistic rather than beautiful, such as several self-portraits that showed mastectomy scars.

Another art form has a wider range: the illness narrative has become a staple of breast cancer literature and is prominent in women's magazines. This may take the form of a restitution or cure narrative (the protagonist seeks a physical or spiritual return to a pre-diagnosis life), a quest narrative (the protagonist must meet a goal before dying), or a chaos narrative (the situation inexorably goes from bad to worse). The cure and quest narratives fit neatly with the breast cancer culture. Chaos narratives, which are rarer in stories about breast cancer, oppose it.

History

William Stewart Halsted, responsible for the radical mastectomy that dramatically reduced death rates due to breast cancer, but later proved to be controversial in its own right.

Breast cancer has been known since ancient times. With no reliable treatments, and with surgical outcomes often fatal, women tended to conceal the possibility of breast cancer as long as possible. With the dramatic improvement in survival rates at the end of the 19th century—the radical mastectomy promoted by William Stewart Halsted raised long-term survival rates from 10% to 50%—efforts to educate women about the importance of early detection and prompt action were begun.

Early campaigns included the "Women's Field Army", run by the American Society for the Control of Cancer (the forerunner of the American Cancer Society) during the 1930s and 1940s. Explicitly using a military metaphor, they promoted early detection and prompt medical intervention as every woman's duty in the war on cancer. In 1952, the first peer-to-peer support group, called Reach to Recovery, was formed. Later taken over by the American Cancer Society, it provided post-mastectomy, in-hospital visits from women who had survived breast cancer, who shared their own experiences, practical advice, and emotional support, but never medical information. This was the first program designed to promote restoration of a feminine appearance, e.g., through providing breast prostheses, as a goal.

Organizations

A wide variety of charitable organizations are involved in breast cancer awareness and support. These organizations do everything from providing practical support, to educating the public, to dispensing millions of dollars for research and treatment. Thousands of small breast cancer organizations exist. The largest and most prominent are:

See also

Footnotes

  1. As an example, the State of Texas pays for breast cancer treatment in women whose income is 200% of the Federal Poverty Income Guideline (Texas Administrative Code §371.7), but to be screened or treated for hypertension, diabetes mellitus, or lung cancer, the income limit is 185% of FPIG Archived 1 February 2011 at the Wayback Machine
  2. Grouped by cause World Health Organization 2004, p. 120

References

  1. King 2006, p. 2
  2. ^ Sulik 2010, pp. 157–210
  3. Arnst 2007
  4. Sulik 2010, p. 22; King 2006, p. 38
  5. Sulik 2010, pp. 133–146
  6. King 2006, p. 111
  7. Moore 2008, p. 43, 65
  8. Sulik 2010, pp. 359–361
  9. Landman 2008
  10. Borrelli 2010
  11. Sulik 2010, pp. 365–366
  12. Sulik 2010, pp. 372–374
  13. Sulik 2010, pp. 48, 370
  14. King 2006, p. xxi
  15. Ehrenreich 2001
  16. Sulik 2010, p. 56
  17. King 2006, pp. 46–49
  18. Ehrenreich 2001
  19. Elliott 2009
  20. King 2006, p. xx
  21. King 2006, p. 15–18
  22. Gustines 2010
  23. Ehrenreich 2001
  24. Burns 2021
  25. Ave 2006
  26. Ehrenreich 2001
  27. Ehrenreich 2001
  28. Levine 2005
  29. Levine 2005
  30. Elliott 2009
  31. Stukin 2006
  32. Singer 2011
  33. King 2006, pp. 61–79
  34. Royal Canadian Mint 2006
  35. Royal Canadian Mint 2006
  36. Mulholland 2010
  37. Landman 2008
  38. Stukin 2006
  39. Singer 2011
  40. Sulik 2010, pp. 366–368
  41. Sulik 2010, pp. 369–372
  42. King 2006
  43. King 2006, pp. 110–111
  44. King 2006, p. 37
  45. Sulik 2010, pp. 205–208
  46. Sulik 2010, p. 125–145
  47. Zuger 2010
  48. Sulik 2010, pp. 158, 243
  49. Sulik 2010, pp. 78–89
  50. Sulik 2010, pp. 42, 101–105, 374
  51. Sulik 2010, pp. 225–272, 277
  52. Sulik 2010, pp. 279–301
  53. Sulik 2010, pp. 279–301
  54. Sulik 2010, pp. 283, 286
  55. Sulik 2010, pp. 243–244
  56. Sulik 2010, pp. 274–277
  57. Sulik 2010, p. 4
  58. Burns 2021
  59. Ehrenreich 2001; Olson 2002, pp. 204–205; Sulik 2010, pp. 200–203
  60. Sulik 2010, pp. 365–366
  61. Olson 2002, pp. 460–469; Sulik 2010, p. 342
  62. Sulik 2010, p. 236
  63. Ehrenreich 2001; Sulik 2010, p. 3
  64. Sulik 2010, p. 319
  65. Ehrenreich 2001
  66. Sulik 2010, p. 98
  67. Ehrenreich 2001; Sulik 2010, p. 373
  68. Ehrenreich 2001; Sulik 2010, pp. 240–242
  69. Sulik 2010, pp. 35–45, 262
  70. Olson 2002, p. 120; Sulik 2010, pp. 37–38, 42, 101–105, 374
  71. Ehrenreich 2001
  72. Ehrenreich 2001
  73. Kingston 2010
  74. Sulik 2010, pp. 372–374
  75. Kingston 2010
  76. Sulik 2010, pp. 308–309
  77. Sulik 2010, p. 57
  78. Sulik 2010, pp. 305–311
  79. Olson 2002, pp. 192–220
  80. Olson 2002, pp. 192–220
  81. Olson 2002, pp. 195–202
  82. Soffa 1994, p. 208
  83. Ehrenreich 2001
  84. Olson 2002, p. 198
  85. Ehrenreich 2001
  86. Ehrenreich 2001
  87. Sulik 2010, p. 4
  88. Mukherjee 2010, pp. 26–27
  89. Olson 2002, pp. 124–144
  90. Lebo et al. 2015
  91. Olson 2002, pp. 124–144
  92. Olson 2002, pp. 121, 171–220
  93. Ehrenreich 2001; Olson 2002, pp. 168–191
  94. Olson 2002, pp. 176, 185–186, 250
  95. O'Mahony et al. 2017
  96. Mulholland 2010
  97. Ave 2006; Forman, Gould & Rizzo 2013, pp. 7–12
  98. Forman, Gould & Rizzo 2013, pp. 7–12
  99. Browne 2001
  100. Browne 2001
  101. Aschwanden 2009
  102. Sulik 2010, pp. 165–171
  103. Sulik 2010, pp. 170–171
  104. Ave 2006
  105. Rosenbaum 2014
  106. Olson 2002, pp. 240–242; Sulik 2010, pp. 74, 263
  107. Welch 2010
  108. Aschwanden 2009
  109. Beck 2012
  110. Aschwanden 2009
  111. Beck 2012
  112. Beck 2012
  113. Ave 2006; King 2006
  114. Sulik 2010, pp. 160–210
  115. Sulik 2010, pp. 130–135
  116. Elliott 2009
  117. Sulik 2010, pp. 209–210
  118. Sulik 2010, p. 376
  119. Sargeant 2014, pp. 271–213
  120. Ave 2006
  121. Forman, Gould & Rizzo 2013, pp. 7–12
  122. Forman, Gould & Rizzo 2013, pp. 7–12
  123. Ave 2006
  124. Ave 2006; King 2006, p. 38
  125. Sulik 2010, p. 204
  126. King 2006, p. 38
  127. Ehrenreich 2001
  128. Ehrenreich 2001
  129. King 2006, pp. vii–xxv, 1–28; Sulik 2010, pp. 55–56, 188–189
  130. Institute of Medicine 2012
  131. Grady 2011
  132. King 2006, p. 38
  133. Levine 2005
  134. Sulik 2010, pp. 229–377
  135. Sulik 2010, pp. 326–332
  136. Sulik 2010, pp. 321–326
  137. Olson 2002, p. 1; King 2006, p. xix
  138. Sulik 2010, pp. 37–38
  139. Levine 2005

Sources

Further reading

Breast cancer
General
Treatment
Types
Ductal
Lobular
Fibroepithelials/stromal
Other
Other
Categories: